<article title='Caffeine'><paragraph><template><target>About</target><arg>the stimulant</arg></template><template><target>pp-semi-indef</target></template><template><target>pp-move-indef</target></template><template><target>Use dmy dates</target><arg name="date">July 2015</arg></template><template><target>infobox drug</target><arg name="verifiedrevid">
</arg><arg name="drug_name"><space/>Caffeine ({{abbr|INN|International Nonproprietary Name}})
</arg><arg name="IUPAC_name"><space/>1,3,7-Trimethylpurine-2,6-dione
</arg><arg name="image"><space/>Koffein - Caffeine.svg
</arg><arg name="alt"><space/>2D structure of caffeine
</arg><arg name="image2"><space/>Caffeine (1) 3D ball.png
</arg><arg name="alt2"><space/>3D structure of caffeine

<space/></arg><arg name="pronounce"><space/>{{IPAc-en|k|æ|ˈ|f|iː|n|,_|ˈ|k|æ|f|iː|n|}}
</arg><arg name="tradename">
</arg><arg name="Drugs.com">{{Drugs.com|monograph|caffeine-caffeine-and-sodium-benzoate-injection-caffeine-citrate}}
</arg><arg name="MedlinePlus">
</arg><arg name="pregnancy_AU"><space/>A
</arg><arg name="pregnancy_US"><space/>C
</arg><arg name="legal_AU"><space/>Unscheduled
</arg><arg name="legal_CA"><space/>Unscheduled
</arg><arg name="legal_DE"><space/>Unscheduled
</arg><arg name="legal_NZ"><space/>Unscheduled
</arg><arg name="legal_UK"><space/>Unscheduled
</arg><arg name="legal_US"><space/>Unscheduled
</arg><arg name="legal_EU"><space/>Unscheduled
</arg><arg name="legal_UN"><space/>Unscheduled
</arg><arg name="dependency_liability"><space/>[[Physical dependence|Physical]]: low–moderate<ref name</arg><arg name="addiction_liability">Low<ref name</arg><arg name="routes_of_administration"><space/>[[Oral route|oral]], [[Insufflation (medicine)|insufflation]], [[coffee enema|enema]], [[Suppository|rectal]], [[intravenous]]
<space/></arg><arg name="onset"><space/>~1 hour<ref name<space/></arg><arg name="bioavailability"><space/>99%<ref name<space/></arg><arg name="protein_bound"><space/>25–36%<ref name</arg><arg name="metabolism"><space/>Primary: [[CYP1A2]]<ref name</arg><arg name="elimination_half-life"><space/>Adults: 3–7&nbsp;hours<ref name</arg><arg name="excretion"><space/>urine (100%)
</arg><arg name="duration_of_action"><space/>3-4 hours<ref name</arg><arg name="metabolites"><space/>[[Paraxanthine]] (84%)<br>[[Theobromine]] (12%)<br>[[Theophylline]] (4%)

<space/></arg><arg name="CAS_number_Ref"><space/>{{cascite|correct|??}}
</arg><arg name="CAS_number"><space/>58-08-2
</arg><arg name="ATC_prefix"><space/>N06B
</arg><arg name="ATC_suffix"><space/>C01
</arg><arg name="PubChem"><space/>2519
</arg><arg name="DrugBank_Ref"><space/>{{drugbankcite|correct|drugbank}}
</arg><arg name="DrugBank"><space/>DB00201
</arg><arg name="ChemSpiderID_Ref"><space/>{{chemspidercite|correct|chemspider}}
</arg><arg name="ChemSpiderID"><space/>2424
</arg><arg name="UNII_Ref"><space/>{{fdacite|correct|FDA}}
</arg><arg name="UNII"><space/>3G6A5W338E
</arg><arg name="KEGG_Ref"><space/>{{keggcite|correct|kegg}}
</arg><arg name="KEGG"><space/>D00528
</arg><arg name="ChEBI_Ref"><space/>{{ebicite|correct|EBI}}
</arg><arg name="ChEBI"><space/>27732
</arg><arg name="ChEMBL_Ref"><space/>{{ebicite|correct|EBI}}
</arg><arg name="ChEMBL"><space/>113
</arg><arg name="PDB_ligand"><space/>CFF
</arg><arg name="IUPHAR_ligand"><space/>407
</arg><arg name="synonyms"><space/>Guaranine<br />Methyltheobromine<br />1,3,7-Trimethylxanthine<br>Theine

<space/></arg><arg name="C">8</arg><arg name="H">10</arg><arg name="N">4</arg><arg name="O">2
</arg><arg name="molecular_weight"><space/>194.19&nbsp;g/mol
</arg><arg name="smiles"><space/>CN1C</arg><arg name="InChI"><space/>1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
</arg><arg name="InChIKey"><space/>RYYVLZVUVIJVGH-UHFFFAOYAW
</arg><arg name="StdInChI_Ref">
</arg><arg name="StdInChI"><space/>1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
</arg><arg name="StdInChIKey_Ref"><space/>{{stdinchicite|correct|chemspider}}
</arg><arg name="StdInChIKey"><space/>RYYVLZVUVIJVGH-UHFFFAOYSA-N

<space/></arg><arg name="density"><space/>1.23
</arg><arg name="solubility"><space/>
</arg><arg name="melting_point"><space/>235
</arg><arg name="melting_high"><space/>238 
</arg><arg name="melting_notes"><space/>(anhydrous)<ref name</arg><arg name="boiling_point"><space/>
</arg><arg name="boiling_notes"><space/>
</arg></template><bold>Caffeine</bold><space/>is a<space/><link><target>central nervous system</target></link><space/>(CNS)<space/><link><target>stimulant</target></link><space/>of the<space/><link><target>methylxanthine</target></link><space/>class of<space/><link><target>psychoactive drug</target><trail>s</trail></link>.<extension extension_name='ref' name="pmid1356551"><template><target>cite journal</target><arg name="author"><space/>Nehlig A, Daval JL, Debry G<space/></arg><arg name="title"><space/>Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects<space/></arg><arg name="journal"><space/>Brain Res. Brain Res. Rev.<space/></arg><arg name="volume"><space/>17<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>139–70<space/></arg><arg name="year"><space/>1992<space/></arg><arg name="pmid"><space/>1356551<space/></arg><arg name="doi"><space/>10.1016/0165-0173(92)90012-B<space/></arg></template></extension><space/>It is the world's most widely consumed<space/><link><target>psychoactive drug</target></link>, but unlike many other psychoactive substances, it is legal and unregulated in nearly all parts of the world. It is a bitter, white crystalline<space/><link><target>purine</target></link>, a<space/><link><target>methylxanthine</target></link><space/><link><target>alkaloid</target></link>, and thus closely related chemically to the<space/><link><target>adenine</target></link><space/>and<space/><link><target>guanine</target></link><space/>contained in<space/><link><target>DNA</target><part>deoxyribonucleic acid</part></link><space/>(DNA) and<space/><link><target>RNA</target><part>ribonucleic acid</part></link><space/>(RNA). It is found in the seeds, nuts, or leaves of a number of plants native to South America and East Asia. The most well known source of caffeine is the seed (commonly incorrectly referred to as the &quot;bean&quot;) of<space/><italics><link><target>Coffea</target></link></italics><space/>plants. Beverages containing caffeine are ingested to relieve or prevent drowsiness and to increase one's energy level. Caffeine is extracted from the plant part containing it for making beverages by<space/><link><target>steeping</target></link><space/>it in water, a process called<space/><link><target>infusion</target></link>. These beverages are very popular; in North America, 90% of adults consume caffeine daily.<extension extension_name='ref' name="demon drink"><template><target>cite journal</target><arg name="author">Lovett R<space/></arg><arg name="title">Coffee: The demon drink?<space/></arg><arg name="journal">New Scientist<space/></arg><arg name="issue">2518<space/></arg><arg name="date">24 September 2005<space/></arg><arg name="url">http://www.newscientist.com/article.ns?id</arg><arg name="subscription">yes</arg></template></extension></paragraph><paragraph>Caffeine is classified by the<space/><link><target>Food and Drug Administration</target></link><space/>as &quot;<link><target>generally recognized as safe</target></link>&quot; (GRAS). Toxic doses, over 10 grams per day for an adult, are much higher than typical dose of under 500 milligrams per day. A cup of coffee contains 80175&amp;nbsp;mg of caffeine, depending on what &quot;bean&quot; (seed) is used and how it is prepared (e.g.<space/><link><target>Drip brew</target><part>drip</part></link>,<space/><link><target>Coffee percolator</target><part>percolation</part></link>, or<space/><link><target>espresso</target></link>). Thus it requires roughly 50100 ordinary cups of coffee to reach a lethal dose. However pure powdered caffeine, which is available as a dietary supplement, can be lethal in tablespoon-sized amounts. There are several known mechanisms of action to explain the effects of caffeine. The most prominent is to reversibly block the action of<space/><link><target>adenosine</target></link><space/>on its receptor, which blocks the onset of drowsiness induced by adenosine. Caffeine also stimulates certain portions of the autonomic nervous system.</paragraph><paragraph>Caffeine can have both positive and negative health effects. It can be used to treat<space/><link><target>bronchopulmonary dysplasia</target></link><space/>of prematurity, and to prevent<space/><link><target>apnea of prematurity</target></link>:<space/><link><target>caffeine citrate</target></link><space/>was placed on the<space/><link><target>WHO Model List of Essential Medicines</target></link><space/>in 2007.<extension extension_name='ref' name="WHOMedList"><template><target>cite book</target><arg name="title"><space/>WHO Model List of Essential Medicines<space/></arg><arg name="url"><space/>http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua</arg><arg name="edition"><space/>18th<space/></arg><arg name="publisher"><space/>[[World Health Organization]]<space/></arg><arg name="accessdate"><space/>23 December 2014<space/></arg><arg name="page"><space/>34 [p. 38 of pdf]<space/></arg><arg name="date"><space/>October 2013<space/></arg><arg name="origyear"><space/>April 2013</arg></template></extension><space/>It may confer a modest protective effect against some diseases,<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Cano-Marquina A, Tarín JJ, Cano A<space/></arg><arg name="title"><space/>The impact of coffee on health<space/></arg><arg name="journal"><space/>Maturitas<space/></arg><arg name="volume"><space/>75<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>7–21<space/></arg><arg name="date"><space/>May 2013<space/></arg><arg name="pmid"><space/>23465359<space/></arg><arg name="doi"><space/>10.1016/j.maturitas.2013.02.002<space/></arg><arg name="url"><space/>http://linkinghub.elsevier.com/retrieve/pii/S0378-5122(13)00047-9<space/></arg><arg name="accessdate"><space/>15 January 2014<space/></arg></template></extension><space/>including<space/><link><target>Parkinson's disease</target></link><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Qi H, Li S<space/></arg><arg name="title"><space/>Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease<space/></arg><arg name="journal"><space/>Geriatr Gerontol Int<space/></arg><arg name="date"><space/>23 July 2003<space/></arg><arg name="pmid"><space/>23879665<space/></arg><arg name="doi"><space/>10.1111/ggi.12123<space/></arg><arg name="volume">14<space/></arg><arg name="pages">430–439</arg></template></extension><space/>and certain types of cancer. One meta-analysis concluded that<space/><link><target>cardiovascular disease</target></link><space/>such as coronary artery disease and stroke is less likely with 35 cups of non-decaffeinated coffee per day but more likely with over 5 cups per day.<extension extension_name='ref' name="Ding2014"><template><target>cite journal</target><arg name="author"><space/>Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB<space/></arg><arg name="title"><space/>Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies.<space/></arg><arg name="journal"><space/>Circulation<space/></arg><arg name="volume"><space/>129<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>643–59<space/></arg><arg name="date"><space/>11 February 2014<space/></arg><arg name="pmid"><space/>24201300<space/></arg><arg name="doi"><space/>10.1161/circulationaha.113.005925<space/></arg></template></extension><space/>Some people experience<space/><link><target>insomnia</target></link><space/>or sleep disruption if they consume caffeine, especially during the evening hours, but others show little disturbance. Evidence of a risk during pregnancy is equivocal; some authorities recommend that pregnant women limit consumption to the equivalent of two cups of coffee per day or less.<extension extension_name='ref' name="MayoPreg2"><template><target>cite web</target><arg name="author">Mayo Clinic staff<space/></arg><arg name="title">Pregnancy Nutrition: Foods to avoid during pregnancy<space/></arg><arg name="url">http://www.mayoclinic.com/health/pregnancy-nutrition/PR00109/NSECTIONGROUP</arg><arg name="publisher">Mayo Clinic<space/></arg><arg name="accessdate">15 April 2012</arg></template></extension><extension extension_name='ref' name="ACOG policy 462 caffeine"><template><target>cite journal</target><arg name="author"><space/>American College of Obstetricians and Gynecologists<space/></arg><arg name="title"><space/>ACOG CommitteeOpinion No. 462: Moderate caffeine consumption during pregnancy<space/></arg><arg name="journal"><space/>Obstet Gynecol<space/></arg><arg name="volume"><space/>116<space/></arg><arg name="issue"><space/>2 Pt 1<space/></arg><arg name="pages"><space/>467–8<space/></arg><arg name="date"><space/>August 2010<space/></arg><arg name="pmid"><space/>20664420<space/></arg><arg name="doi"><space/>10.1097/AOG.0b013e3181eeb2a1<space/></arg></template></extension><space/>Whether or not caffeine is an<space/><link><target>addictive drug</target></link><space/>depends on how an addiction is defined. It can produce a mild form of<space/><link><target>drug dependence</target></link>&amp;nbsp; associated with<space/><link><target>drug withdrawal</target><part>withdrawal symptoms</part></link><space/>such as sleepiness, headache, and irritability&amp;nbsp; when an individual stops using caffeine after repeated daily intake.<extension extension_name='ref' name="Nestler caffeine dependence-addiction"></extension><extension extension_name='ref' name="DSM-5 definitions + addiction-dependence distinction + Caffeine use disorder"></extension><extension extension_name='ref' name="pmid15448977"></extension><space/><link><target>Drug tolerance</target><part>Tolerance</part></link><space/>to the autonomic effects of increased blood pressure and heart rate, and increased urine output, develops with chronic use (i.e., these symptoms become less pronounced or do not occur following consistent use).<template><target>Citation needed</target><arg name="date">November 2014</arg></template></paragraph><paragraph>Caffeine confers a survival advantage on the plant containing it in three ways. First, if it is ingested by an insect feeding on and potentially damaging or killing the plant, caffeine functions as a natural pesticide which can paralyze and kill the insect. Second, droppings from the plant infuse the surrounding soil with caffeine, which can inhibit the growth of and kill competing seedlings (and potentially its own progeny and itself). Third, caffeine can enhance the reward memory of pollinators such as honey bees, thus increasing the numbers of its progeny.<template><target>TOC limit</target><arg>3</arg></template></paragraph><heading level='2'>Uses</heading><paragraph><template><target>Main</target><arg>Health effects of caffeine</arg></template></paragraph><heading level='3'>Medical</heading><paragraph>Caffeine is used in:</paragraph><list type='bullet'><listitem><link><target>bronchopulmonary dysplasia</target></link><space/>in<space/><link><target>premature birth</target><part>premature</part></link><space/>infants for both prevention<extension extension_name='ref' name="pmid21815280"><template><target>cite journal</target><arg name="author"><space/>Kugelman A, Durand M<space/></arg><arg name="title"><space/>A comprehensive approach to the prevention of bronchopulmonary dysplasia<space/></arg><arg name="journal"><space/>Pediatr Pulmonol<space/></arg><arg name="volume"><space/>46<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1153–65<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21815280<space/></arg><arg name="doi"><space/>10.1002/ppul.21508<space/></arg></template></extension><space/>and treatment.<extension extension_name='ref' name="pmid16210843"><template><target>cite journal</target><arg name="author"><space/>Schmidt B<space/></arg><arg name="title"><space/>Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial<space/></arg><arg name="journal"><space/>Biol. Neonate<space/></arg><arg name="volume"><space/>88<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>208–13<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16210843<space/></arg><arg name="doi"><space/>10.1159/000087584<space/></arg></template></extension><space/>It may improve weight gain during therapy<extension extension_name='ref' name="pmid16707748"><template><target>cite journal</target><arg name="author"><space/>Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W<space/></arg><arg name="title"><space/>Caffeine therapy for apnea of prematurity<space/></arg><arg name="journal"><space/>N. Engl. J. Med.<space/></arg><arg name="volume"><space/>354<space/></arg><arg name="issue"><space/>20<space/></arg><arg name="pages"><space/>2112–21<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16707748<space/></arg><arg name="doi"><space/>10.1056/NEJMoa054065</arg></template></extension><space/>and reduce the incidence of cerebral palsy as well as reduce language and cognitive delay.<extension extension_name='ref' name="caffeine for AOP NEJM"><template><target>cite journal</target><arg name="author"><space/>Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W<space/></arg><arg name="title"><space/>Long-term effects of caffeine therapy for apnea of prematurity<space/></arg><arg name="journal"><space/>N. Engl. J. Med.<space/></arg><arg name="volume"><space/>357<space/></arg><arg name="issue"><space/>19<space/></arg><arg name="pages"><space/>1893–902<space/></arg><arg name="date"><space/>November 2007<space/></arg><arg name="pmid"><space/>17989382<space/></arg><arg name="doi"><space/>10.1056/NEJMoa073679<space/></arg></template></extension><extension extension_name='ref' name="caffeine for AOP JAMA 2012"><template><target>cite journal</target><arg name="author"><space/>Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS<space/></arg><arg name="title"><space/>Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity<space/></arg><arg name="journal"><space/>JAMA<space/></arg><arg name="volume"><space/>307<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>275–82<space/></arg><arg name="date"><space/>January 2012<space/></arg><arg name="pmid"><space/>22253394<space/></arg><arg name="doi"><space/>10.1001/jama.2011.2024<space/></arg></template></extension><space/>On the other hand, subtle long-term side effects are possible.<extension extension_name='ref' name="Funk"><template><target>cite journal</target><arg name="author"><space/>Funk GD<space/></arg><arg name="title"><space/>Losing sleep over the caffeination of prematurity<space/></arg><arg name="journal"><space/>J. Physiol. (Lond.)<space/></arg><arg name="volume"><space/>587<space/></arg><arg name="issue"><space/>Pt 22<space/></arg><arg name="pages"><space/>5299–300<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>19915211<space/></arg><arg name="pmc"><space/>2793860<space/></arg><arg name="doi"><space/>10.1113/jphysiol.2009.182303<space/></arg></template></extension></listitem><listitem><link><target>apnea of prematurity</target></link><space/>as a primary treatment,<extension extension_name='ref' name="pmid21127467"><template><target>cite journal</target><arg name="author"><space/>Mathew OP<space/></arg><arg name="title"><space/>Apnea of prematurity: pathogenesis and management strategies<space/></arg><arg name="journal"><space/>J Perinatol<space/></arg><arg name="volume"><space/>31<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>302–10<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21127467<space/></arg><arg name="doi"><space/>10.1038/jp.2010.126<space/></arg></template></extension><space/>but not prevention.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Henderson-Smart</arg><arg name="first1">DJ</arg><arg name="last2">De Paoli</arg><arg name="first2">AG</arg><arg name="title">Prophylactic methylxanthine for prevention of apnoea in preterm infants.</arg><arg name="journal">The Cochrane database of systematic reviews</arg><arg name="date">8 December 2010</arg><arg name="issue">12</arg><arg name="pages">CD000432</arg><arg name="pmid">21154344</arg><arg name="doi">10.1002/14651858.CD000432.pub2</arg></template></extension><extension extension_name='ref' name="IUPHAR"></extension></listitem><listitem><link><target>orthostatic hypotension</target></link><space/>treatment.<extension extension_name='ref' name="IUPHAR"><template><target>cite web</target><arg name="title">Caffeine: Summary of Clinical Use</arg><arg name="url">http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab</arg><arg name="website">IUPHAR Guide to Pharmacology</arg><arg name="publisher">The International Union of Basic and Clinical Pharmacology</arg><arg name="accessdate">13 February 2015</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Gupta</arg><arg name="first1">V</arg><arg name="last2">Lipsitz</arg><arg name="first2">LA</arg><arg name="title">Orthostatic hypotension in the elderly: diagnosis and treatment.</arg><arg name="journal">The American Journal of Medicine</arg><arg name="date">October 2007</arg><arg name="volume">120</arg><arg name="issue">10</arg><arg name="pages">841–7</arg><arg name="pmid">17904451</arg><arg name="doi">10.1016/j.amjmed.2007.02.023</arg></template></extension></listitem></list><heading level='3'>Enhancing performance</heading><paragraph>Caffeine is a<space/><link><target>central nervous system</target></link><space/>and metabolic stimulant,<extension extension_name='ref' name="pmid1356551"></extension><space/>and is used to reduce physical<space/><link><target>fatigue (medical)</target><part>fatigue</part></link><space/>and to prevent or treat<space/><link><target>drowsiness</target></link>. It produces increased wakefulness, improved thought-processing, increased focus, and better general body coordination.<extension extension_name='ref' name="effects"><template><target>cite journal</target><arg name="author">Bolton S<space/></arg><arg name="title">Caffeine: Psychological Effects, Use and Abuse<space/></arg><arg name="journal">Orthomolecular Psychiatry<space/></arg><arg name="volume">10<space/></arg><arg name="issue">3<space/></arg><arg name="pages">202–211<space/></arg><arg name="year">1981<space/></arg><arg name="url">http://orthomolecular.org/library/jom/1981/pdf/1981-v10n03-p202.pdf</arg></template></extension><space/>The amount of caffeine needed to produce these effects varies from person to person, depending on body size and degree of tolerance.<extension extension_name='ref' name="effects"></extension><space/>Desired effects begin approximately one hour after consumption, and a moderate dose usually subsides in about three or four hours.<extension extension_name='ref' name="Poleszak 2015"></extension></paragraph><paragraph>Caffeine has the desired effect of delaying/preventing<space/><link><target>sleep</target></link>, but does not affect all people in the same way. It also improves performance during sleep deprivation.<extension extension_name='ref' name="pmid21531247"><template><target>cite journal</target><arg name="author"><space/>Snel J, Lorist MM<space/></arg><arg name="title"><space/>Effects of caffeine on sleep and cognition<space/></arg><arg name="journal"><space/>Prog. Brain Res.<space/></arg><arg name="volume"><space/>190<space/></arg><arg name="pages"><space/>105–17<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21531247<space/></arg><arg name="doi"><space/>10.1016/B978-0-444-53817-8.00006-2<space/></arg><arg name="isbn"><space/>978-0-444-53817-8<space/></arg><arg name="series"><space/>Progress in Brain Research<space/></arg></template></extension><space/>Shift workers have fewer mistakes caused by drowsiness.<extension extension_name='ref' name="pmid20464765"><template><target>cite journal</target><arg name="author"><space/>Ker K, Edwards PJ, Felix LM, Blackhall K, Roberts I<space/></arg><arg name="title"><space/>Caffeine for the prevention of injuries and errors in shift workers<space/></arg><arg name="journal"><space/>Cochrane Database Syst Rev<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>CD008508<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20464765<space/></arg><arg name="doi"><space/>10.1002/14651858.CD008508<space/></arg><arg name="editor1-last"><space/>Ker<space/></arg><arg name="editor1-first"><space/>Katharine<space/></arg></template></extension></paragraph><paragraph>In<space/><link><target>athletes</target></link>, moderate doses of caffeine can improve sprint,<extension extension_name='ref' name="pmid21058748"><template><target>cite journal</target><arg name="author"><space/>Bishop D<space/></arg><arg name="title"><space/>Dietary supplements and team-sport performance<space/></arg><arg name="journal"><space/>Sports Med<space/></arg><arg name="volume"><space/>40<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>995–1017<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>21058748<space/></arg><arg name="doi"><space/>10.2165/11536870-000000000-00000<space/></arg></template></extension><space/>stamina, endurance,<extension extension_name='ref' name="pmid21411838"><template><target>cite journal</target><arg name="author"><space/>Conger SA, Warren GL, Hardy MA, Millard-Stafford ML<space/></arg><arg name="title"><space/>Does caffeine added to carbohydrate provide additional ergogenic benefit for endurance?<space/></arg><arg name="journal"><space/>Int J Sport Nutr Exerc Metab<space/></arg><arg name="volume"><space/>21<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>71–84<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21411838<space/></arg></template></extension><space/>and team sports performance,<extension extension_name='ref' name="pmid19924012"><template><target>cite journal</target><arg name="author"><space/>Astorino TA, Roberson DW<space/></arg><arg name="title"><space/>Efficacy of acute caffeine ingestion for short-term high-intensity exercise performance: a systematic review<space/></arg><arg name="journal"><space/>J Strength Cond Res<space/></arg><arg name="volume"><space/>24<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>257–65<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>19924012<space/></arg><arg name="doi"><space/>10.1519/JSC.0b013e3181c1f88a<space/></arg></template></extension><space/>but the improvements are usually limited. Some evidence suggests that coffee does not produce the performance-enhancing effects observed in other caffeine sources.<extension extension_name='ref' name="pmid9729561"><template><target>cite journal</target><arg name="author"><space/>Graham TE, Hibbert E, Sathasivam P<space/></arg><arg name="title"><space/>Metabolic and exercise endurance effects of coffee and caffeine ingestion<space/></arg><arg name="journal"><space/>J. Appl. Physiol.<space/></arg><arg name="volume"><space/>85<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>883–9<space/></arg><arg name="date"><space/>September 1998<space/></arg><arg name="pmid"><space/>9729561<space/></arg><arg name="doi"><space/></arg><arg name="url"><space/>http://jap.physiology.org/content/85/3/883.full<space/></arg></template></extension></paragraph><paragraph>Caffeine is a mild<space/><link><target>cognition enhancer</target></link><space/>as it is related to the effect on wakefulness, concentration, and mood.<extension extension_name='ref' name="Cog10"></extension><space/>At normal doses, caffeine improves memory in learning and sleep deprived activities, but has both beneficial and harmful effects on the<space/><link><target>working memory</target></link><space/>depending on the nature of the task.<extension extension_name='ref' name="Cog10"><template><target>cite journal</target><arg name="author"><space/>Nehlig A<space/></arg><arg name="title"><space/>Is caffeine a cognitive enhancer?<space/></arg><arg name="journal"><space/>J. Alzheimers Dis.<space/></arg><arg name="volume"><space/>20 Suppl 1<space/></arg><arg name="pages"><space/>S85–94<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20182035<space/></arg><arg name="doi"><space/>10.3233/JAD-2010-091315<space/></arg><arg name="quote"><space/>Caffeine does not usually affect performance in learning and memory tasks, although caffeine may occasionally have facilitatory or inhibitory effects on memory and learning. Caffeine facilitates learning in tasks in which information is presented passively; in tasks in which material is learned intentionally, caffeine has no effect. Caffeine facilitates performance in tasks involving working memory to a limited extent, but hinders performance in tasks that heavily depend on this, and caffeine appears to improve memory performance under suboptimal alertness. Most studies, however, found improvements in reaction time. The ingestion of caffeine does not seem to affect long-term memory.&nbsp;... Its indirect action on arousal, mood and concentration contributes in large part to its cognitive enhancing properties.</arg></template></extension><space/>Concurrent caffeine and<space/><link><target>L-theanine</target><part><template><target>smallcaps all</target><arg>L</arg></template>-theanine</part></link><space/>use has synergistic psychoactive effects that promote alertness, attention, and<space/><link><target>Task switching (psychology)</target><part>task switching</part></link>;<extension extension_name='ref' name="caffeine and theanine"></extension><space/>these effects are most pronounced during the first hour post-dose.<extension extension_name='ref' name="caffeine and theanine"><template><target>cite journal</target><arg name="vauthors"><space/>Camfield DA, Stough C, Farrimond J, Scholey AB<space/></arg><arg name="title"><space/>Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis<space/></arg><arg name="journal"><space/>Nutr. Rev.<space/></arg><arg name="volume"><space/>72<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>507–22<space/></arg><arg name="year"><space/>2014<space/></arg><arg name="pmid"><space/>24946991<space/></arg><arg name="doi"><space/>10.1111/nure.12120<space/></arg><arg name="url"><space/></arg></template></extension></paragraph><heading level='2'>Side effects</heading><paragraph><link><target>File:Health effects of caffeine.svg</target><part>thumb</part><part>upright=1.2</part><part>Side effects of caffeine</part></link></paragraph><heading level='3'>Physical</heading><paragraph>Caffeine can increase blood pressure and cause<space/><link><target>vasoconstriction</target></link>.<extension extension_name='ref' name="Daniels1998"><template><target>cite journal</target><arg name="pmid">9655769<space/></arg><arg name="url">http://jap.physiology.org/cgi/pmidlookup?view</arg><arg name="name-list-format">vanc</arg><arg name="year">1998<space/></arg><arg name="last1">Daniels<space/></arg><arg name="first1">JW<space/></arg><arg name="last2">Molé<space/></arg><arg name="first2">PA<space/></arg><arg name="last3">Shaffrath<space/></arg><arg name="first3">JD<space/></arg><arg name="last4">Stebbins<space/></arg><arg name="first4">CL<space/></arg><arg name="title">Effects of caffeine on blood pressure, heart rate, and forearm blood flow during dynamic leg exercise<space/></arg><arg name="volume">85<space/></arg><arg name="issue">1<space/></arg><arg name="pages">154–9<space/></arg><arg name="journal">Journal of applied physiology</arg></template></extension><extension extension_name='ref' name="Bracco"><template><target>cite journal</target><arg name="pmid">7485480<space/></arg><arg name="url">http://ajpendo.physiology.org/cgi/pmidlookup?view</arg><arg name="name-list-format">vanc</arg><arg name="title">Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women<space/></arg><arg name="year">1995<space/></arg><arg name="author1">D. Bracco<space/></arg><arg name="journal">American Journal of Physiology<space/></arg><arg name="volume">269<space/></arg><arg name="issue">4<space/></arg><arg name="pages">E671–8<space/></arg><arg name="last2">Ferrarra<space/></arg><arg name="first2">JM<space/></arg><arg name="last3">Arnaud<space/></arg><arg name="first3">MJ<space/></arg><arg name="last4">Jéquier<space/></arg><arg name="first4">E<space/></arg><arg name="last5">Schutz<space/></arg><arg name="first5">Y</arg></template></extension><extension extension_name='ref' name="Mahmud"></extension><space/>Long term consumption at sufficiently high doses has been associated with chronic arterial stiffness.<extension extension_name='ref' name="Mahmud"><template><target>cite journal</target><arg name="pmid">11509481<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">2001<space/></arg><arg name="last1">Mahmud<space/></arg><arg name="first1">A<space/></arg><arg name="last2">Feely<space/></arg><arg name="first2">J<space/></arg><arg name="title">Acute effect of caffeine on arterial stiffness and aortic pressure waveform<space/></arg><arg name="volume">38<space/></arg><arg name="issue">2<space/></arg><arg name="pages">227–31<space/></arg><arg name="journal">Hypertension<space/></arg><arg name="doi">10.1161/01.HYP.38.2.227</arg></template></extension><space/>Coffee and caffeine can affect<space/><link><target>gastrointestinal motility</target></link><space/>and<space/><link><target>gastric acid</target></link><space/>secretion.<extension extension_name='ref' name="Boekema1999"><template><target>cite journal</target><arg name="pmid">10499460<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">1999<space/></arg><arg name="last1">Boekema<space/></arg><arg name="first1">PJ<space/></arg><arg name="last2">Samsom<space/></arg><arg name="first2">M<space/></arg><arg name="last3">Van Berge Henegouwen<space/></arg><arg name="first3">GP<space/></arg><arg name="last4">Smout<space/></arg><arg name="first4">AJ<space/></arg><arg name="title">Coffee and gastrointestinal function: Facts and fiction. A review<space/></arg><arg name="volume">230<space/></arg><arg name="pages">35–9<space/></arg><arg name="journal">Scandinavian journal of gastroenterology<space/></arg><arg name="doi"><space/></arg><arg name="issue">230</arg></template></extension><extension extension_name='ref' name="Cohen1975"><template><target>cite journal</target><arg name="pmid">1177987<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">1975<space/></arg><arg name="last1">Cohen<space/></arg><arg name="first1">S<space/></arg><arg name="last2">Booth<space/></arg><arg name="first2">GH<space/></arg><arg name="title">Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine<space/></arg><arg name="volume">293<space/></arg><arg name="issue">18<space/></arg><arg name="pages">897–9<space/></arg><arg name="doi">10.1056/NEJM197510302931803<space/></arg><arg name="journal">The New England Journal of Medicine</arg></template></extension><extension extension_name='ref' name="Sherwood2004"><template><target>cite book</target><arg name="last1">Sherwood<space/></arg><arg name="first1">Lauralee<space/></arg><arg name="last2">Kell<space/></arg><arg name="first2">Robert<space/></arg><arg name="title">Human Physiology: From Cells to Systems<space/></arg><arg name="edition">1st Canadian<space/></arg><arg name="year">2009<space/></arg><arg name="publisher">Nelsen<space/></arg><arg name="isbn">0-17-644107-7<space/></arg><arg name="pages">613–9</arg></template></extension></paragraph><paragraph>Caffeine increases<space/><link><target>basal metabolic rate</target></link><space/>in adults.<extension extension_name='ref' name="pmid7369170"><template><target>cite journal</target><arg name="pmid">7369170<space/></arg><arg name="url">http://www.ajcn.org/cgi/pmidlookup?view</arg><arg name="name-list-format">vanc</arg><arg name="title">Caffeine and coffee: Their influence on metabolic rate and substrate utilization in normal weight and obese individuals<space/></arg><arg name="year">1980<space/></arg><arg name="first1">KJ<space/></arg><arg name="last1">Acheson<space/></arg><arg name="journal">The American Journal of Clinical Nutrition<space/></arg><arg name="volume">33<space/></arg><arg name="issue">5<space/></arg><arg name="pages">989–97<space/></arg><arg name="last2">Zahorska-Markiewicz<space/></arg><arg name="first2">B<space/></arg><arg name="last3">Pittet<space/></arg><arg name="first3">P<space/></arg><arg name="last4">Anantharaman<space/></arg><arg name="first4">K<space/></arg><arg name="last5">Jéquier<space/></arg><arg name="first5">E</arg></template></extension><extension extension_name='ref' name="pmid2912010"><template><target>cite journal</target><arg name="pmid">2912010<space/></arg><arg name="url">http://www.ajcn.org/cgi/pmidlookup?view</arg><arg name="name-list-format">vanc</arg><arg name="title">Normal caffeine consumption: Influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers<space/></arg><arg name="year">1989<space/></arg><arg name="first1">AG<space/></arg><arg name="last1">Dulloo<space/></arg><arg name="journal">The American Journal of Clinical Nutrition<space/></arg><arg name="volume">49<space/></arg><arg name="issue">1<space/></arg><arg name="pages">44–50<space/></arg><arg name="last2">Geissler<space/></arg><arg name="first2">CA<space/></arg><arg name="last3">Horton<space/></arg><arg name="first3">T<space/></arg><arg name="last4">Collins<space/></arg><arg name="first4">A<space/></arg><arg name="last5">Miller<space/></arg><arg name="first5">DS</arg></template></extension><extension extension_name='ref' name="pmid7486839"><template><target>cite journal</target><arg name="pmid">7486839<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">1995<space/></arg><arg name="last1">Koot<space/></arg><arg name="first1">P<space/></arg><arg name="last2">Deurenberg<space/></arg><arg name="first2">P<space/></arg><arg name="title">Comparison of changes in energy expenditure and body temperatures after caffeine consumption<space/></arg><arg name="volume">39<space/></arg><arg name="issue">3<space/></arg><arg name="pages">135–42<space/></arg><arg name="journal">Annals of nutrition & metabolism<space/></arg><arg name="doi">10.1159/000177854</arg></template></extension><space/>In postmenopausal women, high caffeine consumption can accelerate<space/><link><target>osteoporosis</target><part>bone loss</part></link>.<extension extension_name='ref' name="mp"><template><target>cite web</target><arg name="url">http://www.nlm.nih.gov/medlineplus/ency/article/002445.htm</arg><arg name="title">Caffeine in the diet</arg><arg name="publisher">MedlinePlus, US National Library of Medicine</arg><arg name="date">30 April 2013</arg><arg name="accessdate">2 January 2015</arg></template></extension><extension extension_name='ref' name="Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes"><template><target>cite journal</target><arg name="pmid">11684540<space/></arg><arg name="url">http://www.ajcn.org/cgi/pmidlookup?view</arg><arg name="name-list-format">vanc</arg><arg name="year">2001<space/></arg><arg name="last1">Rapuri<space/></arg><arg name="first1">PB<space/></arg><arg name="last2">Gallagher<space/></arg><arg name="first2">JC<space/></arg><arg name="last3">Kinyamu<space/></arg><arg name="first3">HK<space/></arg><arg name="last4">Ryschon<space/></arg><arg name="first4">KL<space/></arg><arg name="title">Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes<space/></arg><arg name="volume">74<space/></arg><arg name="issue">5<space/></arg><arg name="pages">694–700<space/></arg><arg name="journal">The American journal of clinical nutrition</arg></template></extension></paragraph><paragraph>Caffeine increases urine output acutely, but not chronically.<extension extension_name='ref' name="diuretic"><template><target>cite journal</target><arg name="author"><space/>Maughan RJ, Griffin J<space/></arg><arg name="title"><space/>Caffeine ingestion and fluid balance: a review<space/></arg><arg name="journal"><space/>J Hum Nutr Diet<space/></arg><arg name="volume"><space/>16<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>411–20<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>19774754<space/></arg><arg name="doi"><space/>10.1046/j.1365-277X.2003.00477.x<space/></arg></template></extension><space/>This increase is due to both a<space/><link><target>Polyuria</target><part>diuresis</part></link><space/>(increase in water excretion) and a<space/><link><target>natriuresis</target></link><space/>(increase in saline excretion); it is mediated via proximal tubular adenosine receptor blockade.<extension extension_name='ref'>Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism Am. J. Physiol. Renal Physiol. 1 July 2008 295:F35-F36</extension><space/>The acute increase in urinary output may increase the risk of<space/><link><target>dehydration</target></link>; however, chronic users of caffeine develop a<space/><link><target>Drug tolerance</target><part>tolerance</part></link><space/>to this effect, and experience no increase in urinary output.<extension extension_name='ref' name="really"><template><target>cite news</target><arg name="url">http://www.nytimes.com/2008/03/04/health/nutrition/04real.html?_r</arg><arg name="title">Really? The claim: caffeine causes dehydration<space/></arg><arg name="publisher">New York Times<space/></arg><arg name="accessdate">3 August 2009<space/></arg><arg name="author">Anahad O'connor<space/></arg><arg name="date">4 March 2008</arg></template></extension><extension extension_name='ref' name="armstrong2007"><template><target>cite journal</target><arg name="author"><space/>Armstrong LE, Casa DJ, Maresh CM, Ganio MS<space/></arg><arg name="title"><space/>Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat tolerance<space/></arg><arg name="journal"><space/>Exerc Sport Sci Rev<space/></arg><arg name="volume"><space/>35<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>135–40<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17620932<space/></arg><arg name="doi"><space/>10.1097/jes.0b013e3180a02cc1<space/></arg></template></extension></paragraph><paragraph>Caffeine in low doses may cause weak bronchodilation for up to four hours in asthmatics.<extension extension_name='ref' name="pmid20091514"><template><target>cite journal</target><arg name="author"><space/>Welsh EJ, Bara A, Barley E, Cates CJ<space/></arg><arg name="title"><space/>Caffeine for asthma<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="volume"><space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>CD001112<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20091514<space/></arg><arg name="doi"><space/>10.1002/14651858.CD001112.pub2<space/></arg><arg name="editor1-last"><space/>Welsh<space/></arg><arg name="editor1-first"><space/>Emma J<space/></arg></template></extension></paragraph><heading level='3'>Psychological</heading><paragraph>Minor undesired symptoms from caffeine ingestion not sufficiently severe to warrant a psychiatric diagnosis are common, and include mild anxiety, jitteriness, insomnia, increased sleep latency, and reduced coordination.<extension extension_name='ref' name="effects"></extension><extension extension_name='ref' name="pmid21346331"><template><target>cite journal</target><arg name="author"><space/>Tarnopolsky MA<space/></arg><arg name="title"><space/>Caffeine and creatine use in sport<space/></arg><arg name="journal"><space/>Ann. Nutr. Metab.<space/></arg><arg name="volume"><space/>57 Suppl 2<space/></arg><arg name="pages"><space/>1–8<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>21346331<space/></arg><arg name="doi"><space/>10.1159/000322696<space/></arg></template></extension><space/>Caffeine can have negative effects on<space/><link><target>anxiety disorders</target></link>.<extension extension_name='ref' name="Winston_2005"><template><target>cite journal</target><arg name="author">Winston AP<space/></arg><arg name="title">Neuropsychiatric effects of caffeine<space/></arg><arg name="journal">Advances in Psychiatric Treatment<space/></arg><arg name="year">2005<space/></arg><arg name="volume">11<space/></arg><arg name="issue">6<space/></arg><arg name="pages">432–439<space/></arg><arg name="doi">10.1192/apt.11.6.432</arg></template></extension><space/>According to a 2011 literature review, caffeine use is positively associated with anxiety and panic disorders.<extension extension_name='ref'><template><target>cite journal</target><arg name="pmid">21797659<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">2011<space/></arg><arg name="last1">Vilarim<space/></arg><arg name="first1">MM<space/></arg><arg name="last2">Rocha Araujo<space/></arg><arg name="first2">DM<space/></arg><arg name="last3">Nardi<space/></arg><arg name="first3">AE<space/></arg><arg name="title">Caffeine challenge test and panic disorder: A systematic literature review<space/></arg><arg name="volume">11<space/></arg><arg name="issue">8<space/></arg><arg name="pages">1185–95<space/></arg><arg name="doi">10.1586/ern.11.83<space/></arg><arg name="journal">Expert Review of Neurotherapeutics</arg></template></extension><space/>At high doses, typically greater than 300&amp;nbsp;mg, caffeine can both cause and worsen anxiety.<extension extension_name='ref' name="pmid12204388"><template><target>cite journal</target><arg name="author"><space/>Smith A<space/></arg><arg name="title"><space/>Effects of caffeine on human behavior<space/></arg><arg name="journal"><space/>Food Chem. Toxicol.<space/></arg><arg name="volume"><space/>40<space/></arg><arg name="issue"><space/>9<space/></arg><arg name="pages"><space/>1243–55<space/></arg><arg name="date"><space/>September 2002<space/></arg><arg name="pmid"><space/>12204388<space/></arg><arg name="doi"><space/>10.1016/S0278-6915(02)00096-0<space/></arg></template></extension><space/>For some people, discontinuing caffeine use can significantly reduce anxiety.<extension extension_name='ref' name="pmid2727208"><template><target>cite journal</target><arg name="author"><space/>Bruce MS, Lader M<space/></arg><arg name="title"><space/>Caffeine abstention in the management of anxiety disorders<space/></arg><arg name="journal"><space/>Psychol Med<space/></arg><arg name="volume"><space/>19<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>211–4<space/></arg><arg name="date"><space/>February 1989<space/></arg><arg name="pmid"><space/>2727208<space/></arg><arg name="doi"><space/>10.1017/S003329170001117X<space/></arg></template></extension></paragraph><paragraph>Low doses of caffeine cause increased alertness and decreased fatigue.<extension extension_name='ref' name="effects2"><template><target>cite journal</target><arg name="pmid">12204388<space/></arg><arg name="name-list-format">vanc</arg><arg name="year">2002<space/></arg><arg name="last1">Smith<space/></arg><arg name="first1">A<space/></arg><arg name="title">Effects of caffeine on human behavior<space/></arg><arg name="volume">40<space/></arg><arg name="issue">9<space/></arg><arg name="pages">1243–55<space/></arg><arg name="journal">[[Food and Chemical Toxicology]]<space/></arg><arg name="doi">10.1016/S0278-6915(02)00096-0</arg></template></extension><space/>In moderate doses, caffeine may reduce symptoms of depression and lower<space/><link><target>suicide</target></link><space/>risk.<extension extension_name='ref' name="Psyc10"><template><target>cite journal</target><arg name="author"><space/>Lara DR<space/></arg><arg name="title"><space/>Caffeine, mental health, and psychiatric disorders<space/></arg><arg name="journal"><space/>J. Alzheimers Dis.<space/></arg><arg name="volume"><space/>20 Suppl 1<space/></arg><arg name="pages"><space/>S239–48<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20164571<space/></arg><arg name="doi"><space/>10.3233/JAD-2010-1378<space/></arg></template></extension></paragraph><heading level='3'>Risk during pregnancy</heading><paragraph>Caffeine consumption during pregnancy does not appear to increase the risk of<space/><link><target>congenital malformations</target></link>,<space/><link><target>miscarriage</target></link><space/>or<space/><link><target>growth retardation</target></link><space/>even when consumed in moderate to high amounts.<extension extension_name='ref' name="pmid21370398"><template><target>cite journal</target><arg name="author"><space/>Brent RL, Christian MS, Diener RM<space/></arg><arg name="title"><space/>Evaluation of the reproductive and developmental risks of caffeine<space/></arg><arg name="journal"><space/>Birth Defects Res. B Dev. Reprod. Toxicol.<space/></arg><arg name="volume"><space/>92<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>152–87<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21370398<space/></arg><arg name="pmc"><space/>3121964<space/></arg><arg name="doi"><space/>10.1002/bdrb.20288<space/></arg></template></extension><space/>However, as the data supporting this conclusion is of poor quality, some suggest limiting caffeine consumption during pregnancy.<extension extension_name='ref' name="pmid19238414"><template><target>cite journal</target><arg name="author"><space/>Kuczkowski KM<space/></arg><arg name="title"><space/>Caffeine in pregnancy<space/></arg><arg name="journal"><space/>Arch. Gynecol. Obstet.<space/></arg><arg name="volume"><space/>280<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>695–8<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>19238414<space/></arg><arg name="doi"><space/>10.1007/s00404-009-0991-6<space/></arg></template></extension><extension extension_name='ref' name="pmid19370665"><template><target>cite journal</target><arg name="author"><space/>Jahanfar S, Sharifah H<space/></arg><arg name="title"><space/>Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome<space/></arg><arg name="journal"><space/>Cochrane Database Syst Rev<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>CD006965<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>19370665<space/></arg><arg name="doi"><space/>10.1002/14651858.CD006965.pub2<space/></arg><arg name="editor1-last"><space/>Jahanfar<space/></arg><arg name="editor1-first"><space/>Shayesteh<space/></arg></template></extension><space/>The UK<space/><link><target>Food Standards Agency</target></link><space/>has recommended that pregnant women should limit their caffeine intake, out of prudence, to less than 200&amp;nbsp;mg of caffeine a day&amp;nbsp; the equivalent of two cups of instant coffee, or one and a half to two cups of fresh coffee.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.food.gov.uk/news/pressreleases/2008/nov/caffeineadvice<space/></arg><arg name="accessdate">3 August 2009<space/></arg><arg name="title">Food Standards Agency publishes new caffeine advice for pregnant women</arg></template></extension><space/>The<space/><link><target>American Congress of Obstetricians and Gynecologists</target></link><space/>(ACOG) concluded in 2010 that caffeine consumption is safe up to 200&amp;nbsp;mg per day in pregnant women.<extension extension_name='ref' name="ACOG policy 462 caffeine"></extension><space/>Although the evidence that caffeine may be harmful during pregnancy is equivocal, there is some evidence that the hormonal changes during pregnancy slow the metabolic clearance of caffeine from the system, causing a given dose to have longer-lasting effects (as long as 15&amp;nbsp;hours in the third trimester).<extension extension_name='ref' name="Fredholm"></extension></paragraph><heading level='3'>Reinforcement disorders</heading><heading level='4'>Addiction</heading><paragraph>Whether or not caffeine can result in an addictive disorder depends on how addiction is defined. Some diagnostic models, such as the<space/><template><target>nowrap</target><arg>[[International Statistical Classification of Diseases and Related Health Problems#ICDM-9|ICDM-9]]</arg></template><space/>and<space/><link><target>ICD-10</target></link>, include a classification of caffeine addiction under a broader diagnostic model.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Budney</arg><arg name="first1">AJ</arg><arg name="last2">Emond</arg><arg name="first2">JA</arg><arg name="title">Caffeine addiction? Caffeine for youth? Time to act!</arg><arg name="journal">Addiction (Abingdon, England)</arg><arg name="date">November 2014</arg><arg name="volume">109</arg><arg name="issue">11</arg><arg name="pages">1771–2</arg><arg name="pmid">24984891</arg><arg name="quote">Academics and clinicians, however, have not yet reached consensus about the potential clinical importance of caffeine addiction (or ‘use disorder’)</arg></template></extension><space/>Some state that certain users can become addicted and therefore unable to decrease use even though they know there are negative health effects.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Meredith</arg><arg name="first1">SE</arg><arg name="last2">Juliano</arg><arg name="first2">LM</arg><arg name="last3">Hughes</arg><arg name="first3">JR</arg><arg name="last4">Griffiths</arg><arg name="first4">RR</arg><arg name="title">Caffeine Use Disorder: A Comprehensive Review and Research Agenda.</arg><arg name="journal">Journal of caffeine research</arg><arg name="date">September 2013</arg><arg name="volume">3</arg><arg name="issue">3</arg><arg name="pages">114–130</arg><arg name="pmid">24761279</arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="last1">Riba</arg><arg name="first1">edited by Allan Tasman, Jerald Kay, Jeffrey A. Lieberman, Michael B. First, Michelle B.</arg><arg name="title">Psychiatry</arg><arg name="date">2014</arg><arg name="isbn">9781118753361</arg><arg name="pages">1446</arg><arg name="edition">Fourth</arg><arg name="url">https://books.google.ca/books?id</arg></template></extension></paragraph><paragraph>Some state that research does not provide support for an underlying biochemical mechanism for caffeine addiction.<extension extension_name='ref' name="Nestler caffeine dependence-addiction"></extension><extension extension_name='ref' name="Cellular basis"><template><target>cite journal</target><arg name="author"><space/>Nestler EJ<space/></arg><arg name="title"><space/>Cellular basis of memory for addiction<space/></arg><arg name="journal"><space/>Dialogues Clin Neurosci<space/></arg><arg name="volume"><space/>15<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>431–443<space/></arg><arg name="date">December 2013<space/></arg><arg name="pmid"><space/>24459410<space/></arg><arg name="pmc"><space/>3898681<space/></arg><arg name="doi"><space/></arg><arg name="quote"><space/>DESPITE THE IMPORTANCE OF NUMEROUS PSYCHOSOCIAL FACTORS, AT ITS CORE, DRUG ADDICTION INVOLVES A BIOLOGICAL PROCESS: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction.&nbsp;... A large body of literature has demonstrated that such ΔFosB induction in D1-type NAc neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement</arg></template></extension><extension extension_name='ref' name="Human-caffeine NAcc neuroimaging"><template><target>cite book</target><arg name="author1">Miller PM</arg><arg name="title">Principles of addiction comprehensive addictive behaviors and disorders</arg><arg name="date">2013</arg><arg name="publisher">Elsevier Academic Press</arg><arg name="isbn">9780123983619</arg><arg name="page">784</arg><arg name="edition">1st</arg><arg name="url">https://books.google.com/books?id</arg><arg name="accessdate">11 July 2015</arg><arg name="chapter">Chapter III: Types of Addiction</arg><arg name="quote">Astrid Nehlig and colleagues present evidence that in animals caffeine does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward. A single photon emission computed tomography (SPECT) assessment of brain activation in humans showed that caffeine activates regions involved in the control of vigilance, anxiety, and cardiovascular regulation but did not affect areas involved in reinforcement and reward.</arg></template></extension><extension extension_name='ref' name="Paper cited by preceding book ref"><template><target>cite journal</target><arg name="vauthors"><space/>Nehlig A, Armspach JP, Namer IJ<space/></arg><arg name="title"><space/>SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence<space/></arg><arg name="journal"><space/>Dialogues Clin Neurosci<space/></arg><arg name="volume"><space/>12<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>255–263<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20623930<space/></arg><arg name="pmc"><space/>3181952<space/></arg><arg name="doi"><space/></arg><arg name="quote"><space/>Caffeine is not considered addictive, and in animals it does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward.&nbsp;... these earlier data plus the present data reflect that caffeine at doses representing about two cups of coffee in one sitting does not activate the circuit of dependence and reward and especially not the main target area, the nucleus accumbens. [10],[11],[12]&nbsp;... Therefore, caffeine appears to be different from drugs of dependence like cocaine, amphetamine, morphine, and nicotine, and does not fulfil the common criteria or the scientific definitions to be considered an addictive substance.<sup>42</sup></arg></template></extension><space/>Other research states it can affect the reward system.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Temple</arg><arg name="first1">JL</arg><arg name="title">Caffeine use in children: what we know, what we have left to learn, and why we should worry.</arg><arg name="journal">Neuroscience and biobehavioral reviews</arg><arg name="date">June 2009</arg><arg name="volume">33</arg><arg name="issue">6</arg><arg name="pages">793–806</arg><arg name="pmid">19428492</arg><arg name="quote">Through these interactions, caffeine is able to directly potentiate dopamine neurotransmission, thereby modulating the rewarding and addicting properties of nervous system stimuli.</arg></template></extension></paragraph><paragraph>&quot;Caffeine addiction&quot; was added to the ICDM-9 and ICD-10; however, its addition was contested with claims that this diagnostic model of caffeine addiction is not supported by evidence.<extension extension_name='ref' name="Nestler caffeine dependence-addiction"></extension><extension extension_name='ref' name="Clinical addiction &amp; dependence"><template><target>cite book</target><arg name="author"><space/>Karch SB<space/></arg><arg name="title"><space/>Karch's pathology of drug abuse<space/></arg><arg name="date"><space/>2009<space/></arg><arg name="publisher"><space/>CRC Press<space/></arg><arg name="location"><space/>Boca Raton<space/></arg><arg name="isbn"><space/>9780849378812<space/></arg><arg name="pages"><space/>229–230<space/></arg><arg name="edition"><space/>4th<space/></arg><arg name="url"><space/>https://books.google.ca/books?id</arg><arg name="quote"><space/>The suggestion has also been made that a caffeine dependence syndrome exists&nbsp;... In one controlled study, dependence was diagnosed in 16 of 99&nbsp;individuals who were evaluated. The median daily caffeine consumption of this group was only 357&nbsp;mg per day (Strain et al., 1994).<br />Since this observation was first published, caffeine addiction has been added as an official diagnosis in ICDM&nbsp;9. This decision is disputed by many and is not supported by any convincing body of experimental evidence.&nbsp;... All of these observations strongly suggest that caffeine does not act on the dopaminergic structures related to addiction, nor does it improve performance by alleviating any symptoms of withdrawal</arg></template></extension><extension extension_name='ref' name="ICD-10 F15.2"><template><target>cite web</target><arg name="title">ICD-10 Version:2015</arg><arg name="url">http://apps.who.int/classifications/icd10/browse/2015/en#/F15.2</arg><arg name="publisher">World Health Organization</arg><arg name="accessdate">10 July 2015</arg><arg name="date">2015<space/></arg><arg name="quote"><space/><br />F15&nbsp;Mental and behavioural disorders due to use of other stimulants, including caffeine&nbsp;...<br /><br />.2&nbsp;Dependence syndrome<br />A cluster of behavioural, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance, and sometimes a physical withdrawal state.<br />The dependence syndrome may be present for a specific psychoactive substance (e.g. tobacco, alcohol, or diazepam), for a class of substances (e.g. opioid drugs), or for a wider range of pharmacologically different psychoactive substances. [Includes:]<br />Chronic alcoholism<br />Dipsomania<br />Drug addiction</arg></template></extension><space/>The<space/><link><target>American Psychiatric Association</target></link>'s<space/><template><target>nowrap</target><arg>[[DSM-5]]</arg></template><space/>does not include the diagnosis of a<space/><italics>caffeine addiction</italics><space/>but propose criteria for the disorder for more study.<extension extension_name='ref' name="Add2014"><template><target>cite journal</target><arg name="last1">Addicott</arg><arg name="first1">MA</arg><arg name="title">Caffeine Use Disorder: A Review of the Evidence and Future Implications.</arg><arg name="journal">Current addiction reports</arg><arg name="date">September 2014</arg><arg name="volume">1</arg><arg name="issue">3</arg><arg name="pages">186–192</arg><arg name="pmid">25089257</arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="last1">Association</arg><arg name="first1">American Psychiatry</arg><arg name="title">Diagnostic and statistical manual of mental disorders : DSM-5</arg><arg name="date">2013</arg><arg name="publisher">American Psychiatric Publishing</arg><arg name="location">Washington [etc.]</arg><arg name="isbn">0890425558</arg><arg name="pages">792–795</arg><arg name="edition">5th</arg></template></extension></paragraph><heading level='4'>Dependence and withdrawal</heading><paragraph>Mild<space/><link><target>physical dependence</target></link><space/>may occur with repeated daily intake;<extension extension_name='ref' name="Nestler caffeine dependence-addiction"></extension><space/>the associated physical withdrawal symptoms such as fatigue, headache, irritability, inability to concentrate, sleepiness or drowsiness,<space/><link><target>abdominal pain</target><part>stomach pain</part></link>, and<space/><link><target>arthralgia</target><part>joint pain</part></link>.<extension extension_name='ref' name="Nestler caffeine dependence-addiction"></extension><extension extension_name='ref' name="pmid15448977"><template><target>cite journal</target><arg name="author"><space/>Juliano LM, Griffiths RR<space/></arg><arg name="title"><space/>A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features<space/></arg><arg name="journal"><space/>Psychopharmacology (Berl.)<space/></arg><arg name="volume"><space/>176<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>1–29<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15448977<space/></arg><arg name="doi"><space/>10.1007/s00213-004-2000-x<space/></arg><arg name="url"><space/>http://neuroscience.jhu.edu/griffiths%20papers/CaffwdReview.2004.pdf<space/></arg><arg name="archiveurl"><space/>http://webcitation.org/6533BsxXt<space/></arg><arg name="archivedate"><space/>29 January 2012<space/></arg></template></extension><space/>Withdrawal headaches are experienced by roughly half of those who stop consuming caffeine for two days following an average daily intake of 235&amp;nbsp;mg.<extension extension_name='ref' name="pmid1528206"><template><target>cite journal</target><arg name="author"><space/>Silverman K, Evans SM, Strain EC, Griffiths RR<space/></arg><arg name="title"><space/>Withdrawal syndrome after the double-blind cessation of caffeine consumption<space/></arg><arg name="journal"><space/>N. Engl. J. Med.<space/></arg><arg name="volume"><space/>327<space/></arg><arg name="issue"><space/>16<space/></arg><arg name="pages"><space/>1109–14<space/></arg><arg name="date"><space/>October 1992<space/></arg><arg name="pmid"><space/>1528206<space/></arg><arg name="doi"><space/>10.1056/NEJM199210153271601<space/></arg></template></extension></paragraph><paragraph>The ICD-10 includes a diagnostic model for<space/><link><target>caffeine dependence</target></link>, but the DSM-5 does not.<extension extension_name='ref' name="DSM-5 definitions + addiction-dependence distinction + Caffeine use disorder"></extension><extension extension_name='ref' name="ICD-10 F15.2"></extension><space/>The<space/><template><target>abbr</target><arg>APA</arg><arg>American Psychiatric Association</arg></template>, which published the DSM-5, acknowledged that there was sufficient evidence in order to create a diagnostic model of caffeine dependence for the DSM-5, but they noted that the<space/><link><target>clinical significance</target></link><space/>of this disorder is unclear.<extension extension_name='ref' name="DSM-5 definitions + addiction-dependence distinction + Caffeine use disorder"></extension><space/>The DSM-5 instead lists &quot;caffeine use disorder&quot; in the<space/><link><target>DSM-5#Section III: emerging measures and models</target><part>emerging models</part></link><space/>section of the manual.<extension extension_name='ref' name="DSM-5 definitions + addiction-dependence distinction + Caffeine use disorder"></extension></paragraph><heading level='5'>Tolerance</heading><paragraph><link><target>Drug tolerance</target><part>Tolerance</part></link><space/>to the desired effect of alertness does not occur following repeated use. Tolerance to some undesired effects, particularly to caffeine's autonomic effects, develops quickly, especially among heavy coffee and energy drink consumers.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.caffeinedependence.org/caffeine_dependence.html<space/></arg><arg name="title">Information about caffeine dependence<space/></arg><arg name="website">Caffeinedependence.org<space/></arg><arg name="accessdate">25 May 2012</arg></template></extension><space/>Some coffee drinkers develop tolerance to its undesired sleep-disrupting effects, but others apparently do not.<extension extension_name='ref' name="Fredholm"><template><target>cite journal</target><arg name="author"><space/>Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE<space/></arg><arg name="title"><space/>Actions of caffeine in the brain with special reference to factors that contribute to its widespread use<space/></arg><arg name="journal"><space/>Pharmacol. Rev.<space/></arg><arg name="volume"><space/>51<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>83–133<space/></arg><arg name="year"><space/>1999<space/></arg><arg name="pmid"><space/>10049999<space/></arg></template></extension></paragraph><heading level='3'>Risk of other diseases</heading><paragraph>Coffee consumption is associated with a lower overall risk of<space/><link><target>cancer</target></link>.<extension extension_name='ref' name="pmid18834663"><template><target>cite journal</target><arg name="author"><space/>Nkondjock A<space/></arg><arg name="title"><space/>Coffee consumption and the risk of cancer: an overview<space/></arg><arg name="journal"><space/>Cancer Lett.<space/></arg><arg name="volume"><space/>277<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>121–5<space/></arg><arg name="date"><space/>May 2009<space/></arg><arg name="pmid"><space/>18834663<space/></arg><arg name="doi"><space/>10.1016/j.canlet.2008.08.022<space/></arg></template></extension><space/>This is primarily due to a decrease in the risks of<space/><link><target>hepatocellular carcinoma</target><part>hepatocellular</part></link><space/>and<space/><link><target>endometrial cancer</target></link>, but it may also have a modest effect on colorectal cancer.<extension extension_name='ref' name="Cancer10"></extension><space/>There does not appear to be a significant protective effect against other types of cancers, and heavy coffee consumption may increase the risk of<space/><link><target>bladder cancer</target></link>.<extension extension_name='ref' name="Cancer10"><template><target>cite journal</target><arg name="author"><space/>Arab L<space/></arg><arg name="title"><space/>Epidemiologic evidence on coffee and cancer<space/></arg><arg name="journal"><space/>Nutrition and cancer<space/></arg><arg name="volume"><space/>62<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>271–83<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20358464<space/></arg><arg name="doi"><space/>10.1080/01635580903407122<space/></arg></template></extension><space/>A protective effect of caffeine against<space/><link><target>Alzheimer's disease</target></link><space/>is possible, but the evidence is inconclusive.<extension extension_name='ref' name="pmid20182026"><template><target>cite journal</target><arg name="author"><space/>Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N<space/></arg><arg name="title"><space/>Caffeine intake and dementia: systematic review and meta-analysis<space/></arg><arg name="journal"><space/>J. Alzheimers Dis.<space/></arg><arg name="volume"><space/>20 Suppl 1<space/></arg><arg name="pages"><space/>S187–204<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20182026<space/></arg><arg name="doi"><space/>10.3233/JAD-2010-091387<space/></arg></template></extension><extension extension_name='ref' name="pmid21427489"><template><target>cite journal</target><arg name="author"><space/>Marques S, Batalha VL, Lopes LV, Outeiro TF<space/></arg><arg name="title"><space/>Modulating Alzheimer's disease through caffeine: a putative link to epigenetics<space/></arg><arg name="journal"><space/>J. Alzheimers Dis.<space/></arg><arg name="volume"><space/>24<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>161–71<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21427489<space/></arg><arg name="doi"><space/>10.3233/JAD-2011-110032<space/></arg></template></extension><extension extension_name='ref' name="pmid20182037"><template><target>cite journal</target><arg name="author"><space/>Arendash GW, Cao C<space/></arg><arg name="title"><space/>Caffeine and coffee as therapeutics against Alzheimer's disease<space/></arg><arg name="journal"><space/>J. Alzheimers Dis.<space/></arg><arg name="volume"><space/>20 Suppl 1<space/></arg><arg name="issue"><space/></arg><arg name="pages"><space/>S117–26<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20182037<space/></arg><arg name="doi"><space/>10.3233/JAD-2010-091249<space/></arg></template></extension><space/>Moderate coffee consumption may decrease the risk of<space/><link><target>cardiovascular disease</target></link>,<extension extension_name='ref' name="Ding2014"></extension><space/>and it may somewhat reduce the risk of<space/><link><target>Diabetes mellitus type 2</target><part>type 2 diabetes</part></link>.<extension extension_name='ref' name="Dam08"><template><target>cite journal</target><arg name="author"><space/>van Dam RM<space/></arg><arg name="title"><space/>Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer<space/></arg><arg name="journal"><space/>Applied physiology, nutrition, and metabolism<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>1269–1283<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>19088789<space/></arg><arg name="doi"><space/>10.1139/H08-120<space/></arg></template></extension><space/>Drinking four or more cups of coffee per day does not affect the risk of<space/><link><target>hypertension</target></link><space/>compared to drinking little or no coffee. However those who drink 13 cups per day may be at a slightly increased risk.<extension extension_name='ref' name="pmid21450934"><template><target>cite journal</target><arg name="author"><space/>Zhang Z, Hu G, Caballero B, Appel L, Chen L<space/></arg><arg name="title"><space/>Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies<space/></arg><arg name="journal"><space/>Am. J. Clin. Nutr.<space/></arg><arg name="volume"><space/>93<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>1212–9<space/></arg><arg name="date"><space/>June 2011<space/></arg><arg name="pmid"><space/>21450934<space/></arg><arg name="doi"><space/>10.3945/ajcn.110.004044<space/></arg></template></extension><space/>Caffeine increases<space/><link><target>intraocular pressure</target></link><space/>in those with<space/><link><target>glaucoma</target></link><space/>but does not appear to affect normal individuals.<extension extension_name='ref' name="pmid20706731"><template><target>cite journal</target><arg name="author"><space/>Li M, Wang M, Guo W, Wang J, Sun X<space/></arg><arg name="title"><space/>The effect of caffeine on intraocular pressure: a systematic review and meta-analysis<space/></arg><arg name="journal"><space/>Graefes Arch. Clin. Exp. Ophthalmol.<space/></arg><arg name="volume"><space/>249<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>435–42<space/></arg><arg name="date"><space/>March 2011<space/></arg><arg name="pmid"><space/>20706731<space/></arg><arg name="doi"><space/>10.1007/s00417-010-1455-1<space/></arg></template></extension><space/>It may protect people from<space/><link><target>liver cirrhosis</target></link>.<extension extension_name='ref' name="pmid19825397"><template><target>cite journal</target><arg name="author"><space/>Muriel P, Arauz J<space/></arg><arg name="title"><space/>Coffee and liver diseases<space/></arg><arg name="journal"><space/>Fitoterapia<space/></arg><arg name="volume"><space/>81<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>297–305<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>19825397<space/></arg><arg name="doi"><space/>10.1016/j.fitote.2009.10.003<space/></arg></template></extension><space/>There is no evidence that coffee stunts a child's growth.<extension extension_name='ref'><template><target>cite book</target><arg name="author">O'Connor A<space/></arg><arg name="title">Never shower in a thunderstorm : surprising facts and misleading myths about our health and the world we live in<space/></arg><arg name="year">2007<space/></arg><arg name="publisher">Times Books<space/></arg><arg name="location">New York<space/></arg><arg name="isbn">978-0-8050-8312-5<space/></arg><arg name="page">144<space/></arg><arg name="edition">1st<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="accessdate">15 January 2014</arg></template></extension><space/>Caffeine may increase the effectiveness of some medications including ones used to treat<space/><link><target>headaches</target></link>.<extension extension_name='ref' name="pmid21302868"><template><target>cite journal</target><arg name="author"><space/>Gilmore B, Michael M<space/></arg><arg name="title"><space/>Treatment of acute migraine headache<space/></arg><arg name="journal"><space/>Am Fam Physician<space/></arg><arg name="volume"><space/>83<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>271–80<space/></arg><arg name="date"><space/>February 2011<space/></arg><arg name="pmid"><space/>21302868<space/></arg><arg name="doi"><space/></arg></template></extension><space/>Caffeine may lessen the severity of<space/><link><target>acute mountain sickness</target></link><space/>if taken a few hours prior to attaining a high altitude.<extension extension_name='ref' name="pmid20367483"><template><target>cite journal</target><arg name="author"><space/>Hackett PH<space/></arg><arg name="title"><space/>Caffeine at high altitude: java at base Camp<space/></arg><arg name="journal"><space/>High Alt. Med. Biol.<space/></arg><arg name="volume"><space/>11<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>13–7<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20367483<space/></arg><arg name="doi"><space/>10.1089/ham.2009.1077<space/></arg></template></extension></paragraph><heading level='2'>Overdose</heading><paragraph><link><target>File:Main symptoms of Caffeine overdose.svg</target><part>thumb</part><part>right</part><part>Primary symptoms of caffeine intoxication<extension extension_name='ref' name="Medline"></extension></part><part>alt=Torso of a young man with overlaid text of main side-effects of caffeine overdose.</part></link></paragraph><paragraph>Consumption of 1,0001,500&amp;nbsp;mg per day is associated with a condition known as<space/><italics>caffeinism.</italics><extension extension_name='ref'><template><target>cite journal</target><arg name="url">http://apt.rcpsych.org/content/11/6/432.full<space/></arg><arg name="title">Neuropsychiatric effects of caffeine<space/></arg><arg name="author">Winston AP, Hardwick E, Jaberi N<space/></arg><arg name="journal">Advances in Psychiatric Treatment<space/></arg><arg name="year">2005<space/></arg><arg name="pages">432–439<space/></arg><arg name="accessdate">19 December 2013<space/></arg><arg name="doi">10.1192/apt.11.6.432<space/></arg><arg name="volume">11<space/></arg><arg name="issue">6</arg></template></extension><space/>Caffeinism usually combines caffeine<space/><link><target>Substance dependence</target><part>dependency</part></link><space/>with a wide range of unpleasant symptoms including nervousness, irritability, restlessness, insomnia, headaches, and palpitations after caffeine use.<extension extension_name='ref'><template><target>cite book</target><arg name="chapter">Caffeinism: History, clinical features, diagnosis, and treatment<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="pages">331–344<space/></arg><arg name="title">Caffeine and Activation Theory: Effects on Health and Behavior<space/></arg><arg name="editor">Smith BD, Gupta U, Gupta BS<space/></arg><arg name="year">2007<space/></arg><arg name="publisher">CRC Press<space/></arg><arg name="isbn">978-0-8493-7102-8<space/></arg><arg name="author">Iancu I, Olmer A, Strous RD<space/></arg><arg name="accessdate">15 January 2014</arg></template></extension></paragraph><paragraph>Caffeine overdose can result in a state of central nervous system over-stimulation called<space/><italics>caffeine intoxication</italics><space/>(<link><target>DSM-IV</target></link><space/>305.90).<extension extension_name='ref' name="DSM-IV"><template><target>cite book</target><arg name="title">Diagnostic and Statistical Manual of Mental Disorders<space/></arg><arg name="edition">4th<space/></arg><arg name="publisher">[[American Psychiatric Association]]<space/></arg><arg name="year">1994<space/></arg><arg name="isbn">0-89042-062-9<space/></arg><arg name="author">American Psychiatric Association.</arg></template></extension><space/>This syndrome typically occurs only after ingestion of large amounts of caffeine, well over the amounts found in typical caffeinated beverages and caffeine tablets (e.g., more than 400500&amp;nbsp;mg at a time). The symptoms of caffeine intoxication are comparable to the symptoms of overdoses of other<space/><link><target>stimulant</target><trail>s</trail></link>: they may include restlessness, fidgeting, anxiety, excitement, insomnia, flushing of the face, increased urination, gastrointestinal disturbance, muscle twitching, a rambling flow of thought and speech, irritability, irregular or rapid heart beat, and<space/><link><target>psychomotor agitation</target></link>.<extension extension_name='ref' name="Medline"><template><target>cite web</target><arg name="title">Caffeine (Systemic)<space/></arg><arg name="publisher">MedlinePlus<space/></arg><arg name="date">25 May 2000<space/></arg><arg name="url">http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202105.html<space/></arg><arg name="archiveurl">https://web.archive.org/web/20070223063601/http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202105.html<space/></arg><arg name="archivedate">23 February 2007<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><space/>In cases of much larger overdoses,<space/><link><target>mania</target></link>,<space/><link><target>depression (mood)</target><part>depression</part></link>, lapses in judgment,<space/><link><target>disorientation</target></link>,<space/><link><target>disinhibition</target></link>, delusions, hallucinations, or psychosis may occur, and<space/><link><target>rhabdomyolysis</target></link><space/>(breakdown of skeletal muscle tissue) can be provoked.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Caffeine overdose<space/></arg><arg name="publisher">MedlinePlus<space/></arg><arg name="date">4 April 2006<space/></arg><arg name="url">http://www.nlm.nih.gov/medlineplus/ency/article/002579.htm<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><extension extension_name='ref' name="Verkhratsky"><template><target>cite journal</target><arg name="author">Verkhratsky A<space/></arg><arg name="title">Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons<space/></arg><arg name="journal">Physiol. Rev.<space/></arg><arg name="volume">85<space/></arg><arg name="issue">1<space/></arg><arg name="pages">201–79<space/></arg><arg name="date">January 2005<space/></arg><arg name="pmid">15618481<space/></arg><arg name="doi">10.1152/physrev.00004.2004<space/></arg></template></extension></paragraph><paragraph>Massive overdose can result in death.<extension extension_name='ref' name="Holmgren"><template><target>cite journal</target><arg name="author">Holmgren P, Nordén-Pettersson L, Ahlner J<space/></arg><arg name="title">Caffeine fatalities&nbsp;– four case reports<space/></arg><arg name="journal">Forensic Science International<space/></arg><arg name="volume">139<space/></arg><arg name="issue">1<space/></arg><arg name="pages">71–3<space/></arg><arg name="year">2004<space/></arg><arg name="pmid">14687776<space/></arg><arg name="doi">10.1016/j.forsciint.2003.09.019<space/></arg></template></extension><extension extension_name='ref'><template><target>cite web</target><arg name="title">FDA Consumer Advice on Powdered Pure Caffeine</arg><arg name="url">http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm405787.htm</arg><arg name="website">FDA</arg><arg name="accessdate">20 August 2014</arg></template></extension><space/>The LD<xhtml:sub>50</xhtml:sub><space/>of caffeine in humans is dependent on individual sensitivity, but is estimated to be 150 to 200 milligrams per kilogram of body mass (75100 cups of coffee for a 70 kilogram adult).<extension extension_name='ref' name="ld50"><template><target>cite journal</target><arg name="title">Factors Affecting Caffeine Toxicity: A Review of the Literature<space/></arg><arg name="author">Peters JM<space/></arg><arg name="journal">The Journal of Clinical Pharmacology and the Journal of New Drugs<space/></arg><arg name="year">1967<space/></arg><arg name="issue">7<space/></arg><arg name="pages">131–141<space/></arg><arg name="url">http://jcp.sagepub.com/content/7/3/131.extract<space/></arg><arg name="doi">10.1002/j.1552-4604.1967.tb00034.x<space/></arg><arg name="volume">7</arg></template></extension><space/>A number of fatalities have been caused by overdoses of readily available powdered caffeine supplements, for which the estimated lethal amount is less than a tablespoon.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Caffeine powder poses deadly risks<space/></arg><arg name="author">Murray Carpenter<space/></arg><arg name="publisher">New York Times<space/></arg><arg name="url">http://well.blogs.nytimes.com/2015/05/18/caffeine-powder-poses-deadly-risks-2<space/></arg><arg name="accessdate">18 May 2015</arg></template></extension><space/>The lethal dose is lower in individuals whose ability to metabolize caffeine is impaired due to genetics or chronic liver disease<extension extension_name='ref' name="liver-damage"><template><target>cite journal</target><arg name="author">Rodopoulos N, Wisén O, Norman A<space/></arg><arg name="title">Caffeine metabolism in patients with chronic liver disease<space/></arg><arg name="journal">Scand. J. Clin. Lab. Invest.<space/></arg><arg name="volume">55<space/></arg><arg name="issue">3<space/></arg><arg name="pages">229–42<space/></arg><arg name="date">May 1995<space/></arg><arg name="pmid">7638557<space/></arg><arg name="doi">10.3109/00365519509089618</arg></template></extension><space/>A death was reported in a man with<space/><link><target>liver cirrhosis</target></link><space/>who overdosed on caffeinated mints.<extension extension_name='ref' name="independent-2013-10-11"><template><target>cite news</target><arg name="url">http://www.independent.co.uk/news/uk/home-news/man-died-after-overdosing-on-caffeine-mints-8874964.html<space/></arg><arg name="title">Man died after overdosing on caffeine mints<space/></arg><arg name="author">Cheston P, Smith L<space/></arg><arg name="date">11 October 2013<space/></arg><arg name="newspaper">The Independent<space/></arg><arg name="accessdate">13 October 2013</arg></template></extension><extension extension_name='ref' name="telegraph-2013-10-13"><template><target>cite news</target><arg name="url">http://www.telegraph.co.uk/health/healthnews/10371921/Warning-over-caffeine-sweets-after-father-dies-from-overdose.html<space/></arg><arg name="title">Warning over caffeine sweets after father dies from overdose<space/></arg><arg name="author">Prynne M<space/></arg><arg name="date">11 October 2013<space/></arg><arg name="newspaper">The Telegraph<space/></arg><arg name="accessdate">13 October 2013</arg></template></extension><extension extension_name='ref' name="mirror-2013-10-12"><template><target>cite web</target><arg name="url">http://www.mirror.co.uk/news/uk-news/john-jackson-family-dad-who-2363193<space/></arg><arg name="title">John Jackson: Family of dad who died from caffeine overdose after eating MINTS want them removed from sale<space/></arg><arg name="author">Fricker M<space/></arg><arg name="date">12 October 2013<space/></arg><arg name="website">Daily Mirror<space/></arg><arg name="accessdate">13 October 2013</arg></template></extension></paragraph><paragraph>Treatment of mild caffeine intoxication is directed toward symptom relief; severe intoxication may require<space/><link><target>peritoneal dialysis</target></link>,<space/><link><target>hemodialysis</target></link>, or<space/><link><target>hemofiltration</target></link>.<extension extension_name='ref' name="Medline"></extension></paragraph><heading level='2'>Pharmacology</heading><heading level='3'>Pharmacodynamics</heading><paragraph><template><target>Synapse map</target></template><link><target>File:Caffeine and adenosine.svg</target><part>thumb</part><part>250px</part><part>Caffeine's primary mechanism of action is as an<space/><link><target>receptor antagonist</target><part>antagonist</part></link><space/>of<space/><link><target>adenosine</target></link><space/>receptors in the brain</part><part>alt=Two skeletal formulas: left&amp;nbsp; caffeine, right&amp;nbsp; adenosine.</part></link>In the absence of caffeine and when a person is awake and alert, little<space/><link><target>adenosine</target></link><space/>is present in (CNS) neurons. With a continued wakeful state, over time it accumulates in the neuronal<space/><link><target>synapse</target></link>, in turn binding to and activating<space/><link><target>adenosine receptor</target><trail>s</trail></link><space/>found on certain CNS neurons; when activated, these receptors produce a cellular response that ultimately increases<space/><link><target>drowsiness</target></link>. When caffeine is consumed, it<space/><link><target>receptor antagonist</target><part>antagonizes</part></link><space/>adenosine receptors; in other words, caffeine prevents adenosine from activating the receptor by blocking the location on the receptor where adenosine binds to it. As a result, caffeine temporarily prevents or relieves drowsiness, and thus maintains or restores alertness.<extension extension_name='ref' name="Drugbank-Caffeine"></extension></paragraph><heading level='4'>Receptor and ion channel targets</heading><paragraph>Caffeine is a receptor antagonist at all<space/><link><target>adenosine receptor</target></link><space/>subtypes (<link><target>adenosine receptor A1</target><part>A1</part></link>,<space/><link><target>adenosine receptor A2a</target><part>A2A</part></link>,<space/><link><target>adenosine receptor A2b</target><part>A2B</part></link>, and<space/><link><target>adenosine receptor A3</target><part>A3</part></link><space/>receptors).<extension extension_name='ref' name="Drugbank-Caffeine"></extension><space/>Antagonism at these receptors stimulates the<space/><link><target>medulla oblongata</target><part>medullary</part></link><space/>vagal, vasomotor, and<space/><link><target>respiratory center</target><trail>s</trail></link>, which increases respiratory rate, reduces heartrate, and constricts blood vessels.<extension extension_name='ref' name="Drugbank-Caffeine"></extension><space/>Adenosine receptor antagonism also promotes neurotransmitter release (e.g.,<space/><link><target>monoamines</target></link><space/>and<space/><link><target>acetylcholine</target></link>), which endows caffeine with its stimulant effects;<extension extension_name='ref' name="Drugbank-Caffeine"></extension><extension extension_name='ref'><template><target>cite web</target><arg name="url">http://worldofcaffeine.com/caffeine-and-neurotransmitters/<space/></arg><arg name="title">World of Caffeine<space/></arg><arg name="publisher">World of Caffeine<space/></arg><arg name="date">15 June 2013<space/></arg><arg name="accessdate">19 December 2013</arg></template></extension><space/><link><target>adenosine</target></link><space/>acts as an inhibitory neurotransmitter that suppresses activity in the central nervous system.<space/><link><target>Heart palpitation</target><trail>s</trail></link><space/>are caused by blockade of the adenosine A1 receptor.<extension extension_name='ref' name="Drugbank-Caffeine"></extension></paragraph><paragraph>Because caffeine is both water- and lipid-soluble, it readily crosses the<space/><link><target>bloodbrain barrier</target></link><space/>that separates the bloodstream from the interior of the brain. Once in the brain, the principal mode of action is as a nonselective<space/><link><target>Receptor antagonist</target><part>antagonist</part></link><space/>of<space/><link><target>adenosine receptor</target><trail>s</trail></link><space/>(in other words, an agent that reduces the effects of adenosine). The caffeine molecule is structurally similar to adenosine, and is capable of binding to adenosine receptors on the surface of cells without activating them, thereby acting as a<space/><link><target>competitive inhibitor</target></link>.<extension extension_name='ref' name="pmid15095008"><template><target>cite journal</target><arg name="author">Fisone G, Borgkvist A, Usiello A<space/></arg><arg name="title">Caffeine as a psychomotor stimulant: mechanism of action<space/></arg><arg name="journal">Cell. Mol. Life Sci.<space/></arg><arg name="volume">61<space/></arg><arg name="issue">7–8<space/></arg><arg name="pages">857–72<space/></arg><arg name="year">2004<space/></arg><arg name="pmid">15095008<space/></arg><arg name="doi">10.1007/s00018-003-3269-3</arg></template></extension></paragraph><paragraph>In addition to its activity at adenosine receptors, caffeine is an<space/><link><target>Inositol trisphosphate receptor</target><part>inositol triphosphate receptor 1</part></link><space/>antagonist and a voltage-independent activator of the<space/><link><target>ryanodine receptor</target><trail>s</trail></link><space/>(<link><target>RYR1</target></link>,<space/><link><target>RYR2</target></link>, and<space/><link><target>RYR3</target></link>).<extension extension_name='ref' name="IUPHAR caffeine"><template><target>cite web</target><arg name="title">Caffeine</arg><arg name="url">http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab</arg><arg name="website">IUPHAR</arg><arg name="publisher">International Union of Basic and Clinical Pharmacology</arg><arg name="accessdate">2 November 2014</arg></template></extension><space/>It is also a competitive antagonist of the<space/><link><target>glycine receptor</target><part>ionotropic glycine receptor</part></link>.<extension extension_name='ref' name="pmid19564396"><template><target>cite journal</target><arg name="author"><space/>Duan L, Yang J, Slaughter MM<space/></arg><arg name="title"><space/>Caffeine inhibition of ionotropic glycine receptors<space/></arg><arg name="journal"><space/>J. Physiol. (Lond.)<space/></arg><arg name="volume"><space/>587<space/></arg><arg name="issue"><space/>Pt 16<space/></arg><arg name="pages"><space/>4063–75<space/></arg><arg name="date">August 2009<space/></arg><arg name="pmid"><space/>19564396<space/></arg><arg name="pmc"><space/>2756438<space/></arg><arg name="doi"><space/>10.1113/jphysiol.2009.174797<space/></arg><arg name="url"><space/></arg></template></extension></paragraph><heading level='4'>Enzyme targets</heading><paragraph>Caffeine, like other<space/><link><target>xanthines</target></link>, also acts as a<space/><link><target>phosphodiesterase inhibitor</target></link>.<extension extension_name='ref' name="pmid20164566"><template><target>cite journal</target><arg name="author">Ribeiro JA, Sebastião AM<space/></arg><arg name="title">Caffeine and adenosine<space/></arg><arg name="journal">J. Alzheimers Dis.<space/></arg><arg name="volume">20 Suppl 1<space/></arg><arg name="pages">S3–15<space/></arg><arg name="year">2010<space/></arg><arg name="pmid">20164566<space/></arg><arg name="doi">10.3233/JAD-2010-1379</arg></template></extension><space/>As a competitive nonselective<space/><link><target>phosphodiesterase inhibitor</target></link>,<extension extension_name='ref' name="PDEs-Essayan"><template><target>cite journal</target><arg name="author">Essayan DM<space/></arg><arg name="title">Cyclic nucleotide phosphodiesterases<space/></arg><arg name="journal">J. Allergy Clin. Immunol.<space/></arg><arg name="volume">108<space/></arg><arg name="issue">5<space/></arg><arg name="pages">671–80<space/></arg><arg name="date">November 2001<space/></arg><arg name="pmid">11692087<space/></arg><arg name="doi">10.1067/mai.2001.119555</arg></template></extension><space/>caffeine raises intracellular<space/><link><target>Cyclic adenosine monophosphate</target><part>cAMP</part></link>, activates<space/><link><target>protein kinase A</target></link>,<space/><link><target>TNF inhibitor</target><part>inhibits TNF-alpha</part></link><extension extension_name='ref' name="PTX-Deree"><template><target>cite journal</target><arg name="author">Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R<space/></arg><arg name="title">Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition<space/></arg><arg name="journal">Clinics (Sao Paulo)<space/></arg><arg name="volume">63<space/></arg><arg name="issue">3<space/></arg><arg name="pages">321–8<space/></arg><arg name="date">June 2008<space/></arg><arg name="pmid">18568240<space/></arg><arg name="pmc">2664230<space/></arg><arg name="doi">10.1590/S1807-59322008000300006</arg></template></extension><extension extension_name='ref' name="pmid9927365"><template><target>cite journal</target><arg name="author">Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U<space/></arg><arg name="title">Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages<space/></arg><arg name="journal">Am. J. Respir. Crit. Care Med.<space/></arg><arg name="volume">159<space/></arg><arg name="issue">2<space/></arg><arg name="pages">508–11<space/></arg><arg name="date">February 1999<space/></arg><arg name="pmid">9927365<space/></arg><arg name="doi">10.1164/ajrccm.159.2.9804085<space/></arg><arg name="url">http://ajrccm.atsjournals.org/cgi/pmidlookup?view</arg></template></extension><space/>and<space/><link><target>leukotriene</target></link><extension extension_name='ref' name="LT-Peters-Golden"><template><target>cite journal</target><arg name="author">Peters-Golden M, Canetti C, Mancuso P, Coffey MJ.<space/></arg><arg name="title">Leukotrienes: underappreciated mediators of innate immune responses<space/></arg><arg name="journal">Journal of Immunology<space/></arg><arg name="year">2005<space/></arg><arg name="pages">589–94<space/></arg><arg name="volume">174<space/></arg><arg name="issue">2<space/></arg><arg name="pmid">15634873<space/></arg><arg name="url">http://www.jimmunol.org/cgi/content/full/174/2/589<space/></arg><arg name="doi">10.4049/jimmunol.174.2.589</arg></template></extension><space/>synthesis, and<space/><link><target>Anti-inflammatory</target><part>reduces inflammation</part></link><space/>and<space/><link><target>innate immunity</target></link>.<extension extension_name='ref' name="LT-Peters-Golden"></extension><space/>Caffeine is also significantly implicated in<space/><link><target>cholinergic system</target></link><space/>where it e.g. inhibits enzyme<space/><link><target>acetylcholinesterase</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Pohanka</arg><arg name="first">M<space/></arg><arg name="title"><space/>The effects of caffeine on the cholinergic system.<space/></arg><arg name="journal"><space/>Mini Reviews in Medicinal Chemistry<space/></arg><arg name="volume">14<space/></arg><arg name="issue">6<space/></arg><arg name="pages">543–549<space/></arg><arg name="year">2014<space/></arg><arg name="pmid">24873820<space/></arg><arg name="doi"><space/>10.2174/1389557514666140529223436<space/></arg><arg name="url"><space/>http://www.eurekaselect.com/122494/article</arg></template></extension></paragraph><heading level='4'>Off-target effects</heading><paragraph>Caffeine antagonizes<space/><link><target>adenosine A2A receptor</target><trail>s</trail></link><space/>in the<space/><link><target>ventrolateral preoptic area</target></link><space/>(VLPO), thereby reducing inhibitory<space/><link><target>GABA</target></link><space/><link><target>neurotransmission</target></link><space/>to the<space/><link><target>tuberomammillary nucleus</target></link>, a<space/><link><target>histamine</target><trail>rgic</trail></link><space/>projection nucleus that activation-dependently promotes arousal.<extension extension_name='ref' name="Ferre 2008"><template><target>vcite2 journal</target><arg name="authors"><space/>Ferré S<space/></arg><arg name="title"><space/>An update on the mechanisms of the psychostimulant effects of caffeine<space/></arg><arg name="journal"><space/>J. Neurochem.<space/></arg><arg name="volume"><space/>105<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>1067–1079<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18088379<space/></arg><arg name="doi"><space/>10.1111/j.1471-4159.2007.05196.x<space/></arg><arg name="quote"><space/>On the other hand, our ‘ventral shell of the nucleus accumbens’ very much overlaps with the striatal compartment simply described by De Luca et al. (2007) as ‘nucleus accumbens shell,’ where both studies show that caffeine does not modify the extracellular levels of dopamine. Therefore, the results of both experimental groups are basically the same and point to differential effects of caffeine in different striatal subcompartments. In fact, analyzing the effects of the intrastriatal perfusion of an A1 receptor antagonist in several other striatal compartments showed striking differences compared with the shell of the nucleus accumbens. Thus, A1 receptor blockade signiﬁcantly increased the extracellular concentration of dopamine, but not glutamate, in the core of the nucleus accumbens and in the caudate–putamen and the effect was more pronounced in the most medial compartments (Boryczet al. 2007). In summary, a subregional difference in the A1 receptor-mediated control of glutamate and dopamine release exists in the striatum&nbsp;... A2A receptors play a crucial role in the sleep-promoting effects of adenosine and the arousal-enhancing effects of caffeine (Huang et al. 2007; Ferre´ et al. 2007a). Those A2A receptors are localized in the ventrolateral pre-optic area of the hypothalamus and their stimulation promotes sleep by inducing GABA release in the histaminergic tuberomammillary nucleus, thereby inhibiting the histaminergic arousal system&nbsp;... chronic caffeine exposure counteracts both motor activation and dopamine release in the nucleus accumbens induced by caffeine or an A1 receptor antagonist&nbsp;... An additional factor that might play a signiﬁcant role in caffeine tolerance is the signiﬁcant increase in plasma and extracellular concentrations of adenosine with chronic caffeine exposure&nbsp;... Caffeine produces its motor and reinforcing effects by releasing the pre- and post-synaptic brakes that adenosine imposes on dopaminergic neurotransmission in the SSM</arg></template></extension><space/>Disinhibition of the tuberomammillary nucleus is the chief mechanism by which caffeine produces wakefulness-promoting effects.<extension extension_name='ref' name="Ferre 2008"></extension></paragraph><heading level='3'>Pharmacokinetics</heading><paragraph>[[File:Caffeine metabolites.svg|thumb|250px|Caffeine is metabolized in the liver into three primary metabolites:<link><target>paraxanthine</target></link><space/>(84%),<space/><link><target>theobromine</target></link><space/>(12%), and<space/><link><target>theophylline</target></link><space/>(4%)|alt=A diagram featuring 4 skeletal chemical formulas. Top (caffeine) relates to similar compounds paraxanthine, theobromine and theophylline.]]</paragraph><paragraph>Caffeine from coffee or other beverages is absorbed by the small intestine within 45 minutes of ingestion and distributed throughout all bodily tissues.<extension extension_name='ref' name="pmid9329065"><template><target>cite journal</target><arg name="author">Liguori A, Hughes JR, Grass JA<space/></arg><arg name="title">Absorption and subjective effects of caffeine from coffee, cola and capsules<space/></arg><arg name="journal">Pharmacol. Biochem. Behav.<space/></arg><arg name="volume">58<space/></arg><arg name="issue">3<space/></arg><arg name="pages">721–6<space/></arg><arg name="year">1997<space/></arg><arg name="pmid">9329065<space/></arg><arg name="doi">10.1016/S0091-3057(97)00003-8</arg></template></extension><space/>Peak blood concentration is reached within 12&amp;nbsp;hours.<template><target>Citation needed</target><arg name="date">March 2015</arg></template><space/>It is eliminated by<space/><link><target>rate equation#First-order reactions</target><part>first-order kinetics</part></link>.<extension extension_name='ref' name="pmid7333346"><template><target>cite journal</target><arg name="author"><space/>Newton R, Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ, Bradbrook ID<space/></arg><arg name="title"><space/>Plasma and salivary pharmacokinetics of caffeine in man<space/></arg><arg name="journal"><space/>Eur. J. Clin. Pharmacol.<space/></arg><arg name="volume"><space/>21<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>45–52<space/></arg><arg name="year"><space/>1981<space/></arg><arg name="pmid"><space/>7333346<space/></arg><arg name="doi"><space/>10.1007/BF00609587<space/></arg></template></extension><space/>Caffeine can also be absorbed rectally, evidenced by suppositories of<space/><link><target>ergotamine</target></link><space/><link><target>tartrate</target></link><space/>and caffeine (for the relief of<space/><link><target>migraine</target></link>)<extension extension_name='ref' name="pmid13165929"><template><target>cite journal</target><arg name="author"><space/>Graham JR<space/></arg><arg name="title"><space/>Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine<space/></arg><arg name="journal"><space/>N. Engl. J. Med.<space/></arg><arg name="volume"><space/>250<space/></arg><arg name="issue"><space/>22<space/></arg><arg name="pages"><space/>936–8<space/></arg><arg name="year"><space/>1954<space/></arg><arg name="pmid"><space/>13165929<space/></arg><arg name="doi"><space/>10.1056/NEJM195406032502203<space/></arg></template></extension><space/>and<space/><link><target>chlorobutanol</target></link><space/>and caffeine (for the treatment of<space/><link><target>hyperemesis</target></link>).<extension extension_name='ref' name="pmid17553397"><template><target>cite journal</target><arg name="author"><space/>Brødbaek HB, Damkier P<space/></arg><arg name="title"><space/>The treatment of hyperemesis gravidarum with chlorobutanol-caffeine rectal suppositories in Denmark: practice and evidence<space/></arg><arg name="language"><space/>Danish<space/></arg><arg name="journal"><space/>Ugeskr. Laeg.<space/></arg><arg name="volume"><space/>169<space/></arg><arg name="issue"><space/>22<space/></arg><arg name="pages"><space/>2122–3<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17553397<space/></arg></template></extension></paragraph><paragraph>Caffeine's<space/><link><target>biological half-life</target></link>&amp;nbsp; the time required for the body to eliminate one-half of a dose&amp;nbsp; varies widely among individuals according to factors such as pregnancy, other drugs,<space/><link><target>liver enzymes</target><part>liver enzyme</part></link><space/>function level (needed for caffeine metabolism) and age. In healthy adults, caffeine's half-life is between 37&amp;nbsp;hours.<extension extension_name='ref' name="Drugbank-Caffeine"></extension><space/><link><target>Nicotine</target></link><space/>decreases the half-life by 3050%,<extension extension_name='ref' name="Fredholm"></extension><space/>while<space/><link><target>oral contraceptives</target></link><space/>can double it<extension extension_name='ref' name="Fredholm"></extension><space/>and pregnancy can raise it to as much as 15&amp;nbsp;hours during the last trimester.<extension extension_name='ref' name="Fredholm"></extension><space/>In newborns the half-life can be 80&amp;nbsp;hours or more, dropping very rapidly with age, possibly to less than the adult value by age 6 months.<extension extension_name='ref' name="Fredholm"></extension><space/>The antidepressant<space/><link><target>fluvoxamine</target></link><space/>(Luvox) reduces the clearance of caffeine by more than 90%, and increases its elimination half-life more than tenfold; from 4.9&amp;nbsp;hours to 56&amp;nbsp;hours.<extension extension_name='ref' name="half-life"><template><target>cite web</target><arg name="url">http://www.medscape.com/druginfo/druginteractions?drug_408</arg><arg name="title">Drug Interaction: Caffeine Oral and Fluvoxamine Oral<space/></arg><arg name="publisher">Medscape Multi-Drug Interaction Checker</arg></template></extension></paragraph><paragraph>Caffeine is<space/><link><target>metabolism</target><part>metabolized</part></link><space/>in the<space/><link><target>liver</target></link><space/>by the<space/><link><target>cytochrome P450 oxidase</target></link><space/>enzyme system, in particular, by the<space/><link><target>CYP1A2</target></link><space/>isozyme, into three dimethyl<link><target>xanthine</target><trail>s</trail></link>,<extension extension_name='ref'><template><target>cite web</target><arg name="title">Caffeine<space/></arg><arg name="publisher">The Pharmacogenetics and Pharmacogenomics Knowledge Base<space/></arg><arg name="url">http://www.pharmgkb.org/do/serve?objId</arg><arg name="accessdate">25 October 2010</arg></template></extension><space/>each of which has its own effects on the body:</paragraph><list type='bullet'><listitem><link><target>Paraxanthine</target></link><space/>(84%): Increases<space/><link><target>lipolysis</target></link>, leading to elevated<space/><link><target>glycerol</target></link><space/>and free<space/><link><target>fatty acid</target></link><space/>levels in<space/><link><target>blood plasma</target></link>.</listitem><listitem><link><target>Theobromine</target></link><space/>(12%): Dilates<space/><link><target>blood vessel</target><trail>s</trail></link><space/>and increases<space/><link><target>urine</target></link><space/>volume. Theobromine is also the principal<space/><link><target>alkaloid</target></link><space/>in the<space/><link><target>cocoa bean</target></link><space/>(<link><target>chocolate</target></link>).</listitem><listitem><link><target>Theophylline</target></link><space/>(4%): Relaxes<space/><link><target>smooth muscle</target><trail>s</trail></link><space/>of the<space/><link><target>bronchus</target><part>bronchi</part></link>, and is used to treat<space/><link><target>asthma</target></link>. The<space/><link><target>therapeutic dose</target></link><space/>of theophylline, however, is many times greater than the levels attained from caffeine metabolism.<template><target>citation needed</target><arg name="date">October 2011</arg></template></listitem></list><paragraph><link><target>1,3,7-Trimethyluric acid</target></link><space/>is a minor caffeine metabolite.<extension extension_name='ref' name="Drugbank-Caffeine"></extension><space/>Each of these metabolites is further metabolized and then excreted in the urine. Caffeine can accumulate in individuals with severe<space/><link><target>liver disease</target></link>, increasing its half-life.<extension extension_name='ref' name="pmid18762933"><template><target>cite journal</target><arg name="author"><space/>Verbeeck RK<space/></arg><arg name="title"><space/>Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction<space/></arg><arg name="journal"><space/>Eur. J. Clin. Pharmacol.<space/></arg><arg name="volume"><space/>64<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1147–61<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18762933<space/></arg><arg name="doi"><space/>10.1007/s00228-008-0553-z<space/></arg></template></extension></paragraph><paragraph>A 2011 review found that increased caffeine intake was associated with a variation in two genes that increase the rate of caffeine catabolism. Subjects who had this<space/><link><target>mutation</target></link><space/>on both<space/><link><target>chromosomes</target></link><space/>consumed 40&amp;nbsp;mg more caffeine per day than others.<extension extension_name='ref' name="Gibson2011"><template><target>cite journal</target><arg name="author"><space/>Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, Berndt SI, Boerwinkle E, Chanock S, Chatterjee N, Couper D, Curhan G, Heiss G, Hu FB, Hunter DJ, Jacobs K, Jensen MK, Kraft P, Landi MT, Nettleton JA, Purdue MP, Rajaraman P, Rimm EB, Rose LM, Rothman N, Silverman D, Stolzenberg-Solomon R, Subar A, Yeager M, Chasman DI, van Dam RM, Caporaso NE<space/></arg><arg name="title"><space/>Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption<space/></arg><arg name="journal"><space/>PLoS Genet.<space/></arg><arg name="volume"><space/>7<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>e1002033<space/></arg><arg name="date"><space/>April 2011<space/></arg><arg name="pmid"><space/>21490707<space/></arg><arg name="pmc"><space/>3071630<space/></arg><arg name="doi"><space/>10.1371/journal.pgen.1002033<space/></arg><arg name="editor1-last"><space/>Gibson<space/></arg><arg name="editor1-first"><space/>Greg<space/></arg></template></extension><space/>This is presumably due to the need for a higher intake to achieve a comparable desired effect, not that the gene &quot;forces&quot; people to drink coffee.</paragraph><heading level='2'>Physical and chemical properties</heading><paragraph>Pure<space/><link><target>anhydrous</target></link><space/>caffeine is a white odorless powder with a melting point of 235238&amp;nbsp;C.<extension extension_name='ref' name="Pubchem properties"></extension><extension extension_name='ref' name="ChemSpider"></extension><space/>Caffeine is moderately soluble in water at room temperature (2&amp;nbsp;g/100 mL), but very soluble in boiling water (66&amp;nbsp;g/100 mL).<extension extension_name='ref' name="solu"></extension><space/>It is also moderately soluble in ethanol (1.5&amp;nbsp;g/100 mL).<extension extension_name='ref' name="solu"><template><target>cite book</target><arg name="title">The Merck Index<space/></arg><arg name="edition">12th<space/></arg><arg name="editor">Susan Budavari<space/></arg><arg name="publisher">Merck & Co., Inc.<space/></arg><arg name="place">Whitehouse Station, NJ<space/></arg><arg name="year">1996<space/></arg><arg name="page">1674</arg></template></extension><space/>It is weakly basic (pK<xhtml:sub>a</xhtml:sub><space/>= ~0.6) requiring strong acid to protonate it.<extension extension_name='ref' name="pKa">This is the pK<xhtml:sub>a</xhtml:sub><space/>for protonated caffeine, given as a range of values included in<space/><template><target>cite book</target><arg name="title">Profiles of Drug Substances, Excipients and Related Methodology, volume 33: Critical Compilation of pK<sub>a</sub><space/>Values for Pharmaceutical Substances<space/></arg><arg name="author">Harry G. Brittain, Richard J. Prankerd<space/></arg><arg name="publisher">Academic Press<space/></arg><arg name="year">2007<space/></arg><arg name="isbn">0-12-260833-X<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="page">15<space/></arg><arg name="accessdate">15 January 2014</arg></template></extension><space/>Caffeine does not contain any<space/><link><target>stereogenic</target></link><space/>centers<extension extension_name='ref' name="isbn0-7614-2242-0"><template><target>cite book</target><arg name="author">Klosterman L<space/></arg><arg name="title">The Facts About Caffeine (Drugs)<space/></arg><arg name="publisher">Benchmark Books (NY)<space/></arg><arg name="year">2006<space/></arg><arg name="page">43<space/></arg><arg name="isbn">0-7614-2242-0</arg></template></extension><space/>and hence is classified as an<space/><link><target>chirality (chemistry)</target><part>achiral</part></link><space/>molecule.<extension extension_name='ref' name="isbn1-58409-016-2"><template><target>cite book</target><arg name="author">Vallombroso T<space/></arg><arg name="title">Organic Chemistry Pearls of Wisdom<space/></arg><arg name="publisher">Boston Medical Publishing Corp<space/></arg><arg name="year">2001<space/></arg><arg name="page">43<space/></arg><arg name="isbn">1-58409-016-2</arg></template></extension></paragraph><paragraph>The<space/><link><target>xanthine</target></link><space/>core of caffeine contains two fused rings, a<space/><link><target>pyrimidinedione</target></link><space/>and<space/><link><target>imidazole</target></link>. The pyrimidinedione in turn contains two<space/><link><target>amide</target></link><space/>functional groups that exist predominately in a<space/><link><target>zwitterion</target><trail>ic</trail></link><space/><link><target>resonance (chemistry)</target><part>resonance</part></link><space/>the location from which the nitrogen atoms are double bonded to their adjacent amide carbons atoms. Hence all six of the atoms within the pyrimidinedione ring system are sp<xhtml:sup>2</xhtml:sup><space/><link><target>orbital hybridization</target><part>hybridized</part></link><space/>and planar. Therefore, the fused 5,6 ring core of caffeine contains a total of ten<space/><link><target>pi bond</target><part>pi electrons</part></link><space/>and hence according to<space/><link><target>Hckel's rule</target></link><space/>is<space/><link><target>aromaticity</target><part>aromatic</part></link>.<extension extension_name='ref' name="urlquantum.esu.edu"><template><target>cite web</target><arg name="url">http://quantum.esu.edu/~scady/Chem495/keskineva.pdf<space/></arg><arg name="title">Chemistry of Caffeine<space/></arg><arg name="author">Keskineva N<space/></arg><arg name="format">PDF<space/></arg><arg name="work"><space/></arg><arg name="publisher">Chemistry Department, East Stroudsburg University<space/></arg><arg name="accessdate">2 January 2014</arg></template></extension></paragraph><heading level='3'>Biosynthesis</heading><paragraph>Caffeine may be synthesized from<space/><link><target>dimethylurea</target></link><space/>and<space/><link><target>malonic acid</target></link>,<extension extension_name='ref' name="isbn1-58829-173-1"><template><target>cite book</target><arg name="author">Temple NJ, Wilson T<space/></arg><arg name="title">Beverages in Nutrition and Health<space/></arg><arg name="publisher">Humana Press<space/></arg><arg name="location">Totowa, NJ<space/></arg><arg name="year">2003<space/></arg><arg name="page">172<space/></arg><arg name="isbn">1-58829-173-1</arg></template></extension><extension extension_name='ref' name="US2785162"><template><target>cite patent</target><arg name="country">US<space/></arg><arg name="number">2785162<space/></arg><arg name="status">patent<space/></arg><arg name="title">Process for the formylation of a 5-nitrouracil<space/></arg><arg name="pubdate">12 March 1957<space/></arg><arg name="fdate">23 April 1954<space/></arg><arg name="inventor">Swidinsky J, Baizer MM<space/></arg><arg name="assign1">New York Quinine and Chemical Works, Inc.</arg></template></extension><extension extension_name='ref' name="Zajac_2003"><template><target>cite journal</target><arg name="author">Zajac MA, Zakrzewski AG, Kowal MG, Narayan S<space/></arg><arg name="title">A Novel Method of Caffeine Synthesis from Uracil<space/></arg><arg name="journal">Synthetic Communications<space/></arg><arg name="year">2003<space/></arg><arg name="volume">33<space/></arg><arg name="issue">19<space/></arg><arg name="pages">3291–3297<space/></arg><arg name="doi">10.1081/SCC-120023986<space/></arg><arg name="url">http://www.umich.edu/~chemh215/CHEM216/Honors%20Cup_old/HCProposal/caffeine.pdf</arg></template></extension><space/>but is rarely obtained from synthesis since it is readily available as a byproduct of decaffeination.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Simon Tilling<space/></arg><arg name="publisher">[[Bristol University]]<space/></arg><arg name="url">http://www.chm.bris.ac.uk/webprojects2001/tilling/synthesis.htm<space/></arg><arg name="title">Crystalline Caffeine<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><template><target>Multiple image</target><arg name="align"><space/>center
</arg><arg name="direction"><space/>horizontal

</arg><arg name="image1"><space/>Caffeine biosynthesis.tif
</arg><arg name="width1"><space/>300
</arg><arg name="alt1"><space/>Synthesis diagram
</arg><arg name="caption1"><space/>Caffeine [[biosynthesis]]<ref name</arg><arg name="image2"><space/>Caffeine synthesis.tif
</arg><arg name="width2"><space/>385
</arg><arg name="alt2"><space/>Synthesis diagram
</arg><arg name="caption2"><space/>Caffeine [[Chemical synthesis|laboratory synthesis]]<ref name</arg></template></paragraph><heading level='3'>Detection in body fluids</heading><paragraph>Caffeine can be quantified in blood, plasma, or serum to monitor therapy in neonates, confirm a diagnosis of poisoning, or facilitate a medicolegal death investigation. Plasma caffeine levels are usually in the range of 210&amp;nbsp;mg/L in coffee drinkers, 1236&amp;nbsp;mg/L in neonates receiving treatment for apnea, and 40400&amp;nbsp;mg/L in victims of acute overdosage. Urinary caffeine concentration is frequently measured in competitive sports programs, for which a level in excess of 15&amp;nbsp;mg/L is usually considered to represent abuse.<extension extension_name='ref'><template><target>cite book</target><arg name="author">Baselt R<space/></arg><arg name="title">Disposition of Toxic Drugs and Chemicals in Man<space/></arg><arg name="edition">9th<space/></arg><arg name="publisher">Biomedical Publications<space/></arg><arg name="location">Seal Beach, CA<space/></arg><arg name="year">2011<space/></arg><arg name="pages">236–9<space/></arg><arg name="isbn">0-931890-08-X</arg></template></extension></paragraph><heading level='3'>Analogs</heading><paragraph>Some analog substances have been created which mimic caffeine's properties with either function or structure or both, one of the latter is the drug<space/><link><target>DMPX</target></link>.<extension extension_name='ref' name="DMPX"><link type='external' href='http://www.ncbi.nlm.nih.gov/pubmed/3193854'>3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs.</link><space/>Life Sci. 1988;43(21):167184. PMID 3193854</extension></paragraph><heading level='2'>Natural occurrence</heading><paragraph>Around sixty plant species are known to contain caffeine.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.medscape.com/viewarticle/780334</arg><arg name="title">Which Plants Contain Caffeine?
</arg><arg name="work">medscape.com</arg></template></extension><space/>Common sources are the &quot;bean&quot; (seed) of the<space/><link><target>coffea arabica</target><part>coffee plant</part></link><space/>(the quantity varies, but 1.3% is a typical value<extension extension_name='ref'>For more information, see<space/><template><target>cite web</target><arg name="title">Frequently Asked Questions about Coffee and Caffeine</arg><arg name="url">http://www.faqs.org/faqs/caffeine-faq/</arg><arg name="author">Alejandro Lopez-Ortiz</arg></template></extension>); in the leaves of the<space/><link><target>camellia sinensis</target><part>tea bush</part></link>; and in<space/><link><target>kola nut</target><trail>s</trail></link>. Other sources include<space/><link><target>ilex vomitoria</target><part>yaupon holly</part></link><space/>leaves, South American holly<space/><link><target>yerba mate</target></link><space/>leaves, seeds from Amazonian maple<space/><link><target>guarana</target></link><space/>berries, and Amazonian holly<space/><link><target>ilex guayusa</target><part>guayusa</part></link><space/>leaves. Temperate climates around the world have produced unrelated caffeine containing plants.</paragraph><paragraph>Caffeine in plants acts as a natural<space/><link><target>pesticide</target></link>: it can paralyze and kill predator insects feeding on the plant:<extension extension_name='ref' name="insecticide"><template><target>cite journal</target><arg name="author"><space/>Nathanson JA<space/></arg><arg name="title"><space/>Caffeine and related methylxanthines: possible naturally occurring pesticides<space/></arg><arg name="journal"><space/>Science<space/></arg><arg name="volume"><space/>226<space/></arg><arg name="issue"><space/>4671<space/></arg><arg name="pages"><space/>184–7<space/></arg><arg name="year"><space/>1984<space/></arg><arg name="pmid"><space/>6207592<space/></arg><arg name="doi"><space/>10.1126/science.6207592<space/></arg></template></extension><space/>high caffeine levels are found in coffee seedlings when they are developing foliage and lack mechanical protection.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Frischknecht PM, Ulmer-Dufek J, Baumann TW<space/></arg><arg name="title">Purine alkaloid formation in buds and developing leaflets of Coffea arabica: Expression of an optimal defence strategy?<space/></arg><arg name="journal">Phytochemistry<space/></arg><arg name="volume">25<space/></arg><arg name="pages">613–6<space/></arg><arg name="year">1986<space/></arg><arg name="doi">10.1016/0031-9422(86)88009-8<space/></arg><arg name="issue">3</arg></template></extension><space/>In addition, high caffeine levels are found in the surrounding soil of coffee seedlings, which inhibits seed germination of nearby coffee seedlings, thus giving seedlings with the highest caffeine levels fewer competitors for existing resources for survival.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Baumann TW<space/></arg><arg name="title">Metabolism and excretion of caffeine during germination of Coffea arabica L<space/></arg><arg name="journal">Plant and Cell Physiology<space/></arg><arg name="volume">25<space/></arg><arg name="issue">8<space/></arg><arg name="pages">1431–6<space/></arg><arg name="year">1984<space/></arg><arg name="url">http://pcp.oxfordjournals.org/content/25/8/1431.abstract</arg></template></extension></paragraph><paragraph>The differing perceptions in the effects of ingesting beverages made from various plants containing caffeine could be explained by the fact that these beverages also contain varying mixtures of other<space/><link><target>methylxanthine</target></link><space/><link><target>alkaloid</target><trail>s</trail></link>, including the<space/><link><target>cardiac</target></link><space/>stimulants<space/><link><target>theophylline</target></link><space/>and<space/><link><target>theobromine</target></link>, and<space/><link><target>polyphenol</target><trail>s</trail></link><space/>that can form insoluble complexes with caffeine.<extension extension_name='ref' name="Ref-1"><template><target>cite book</target><arg name="author">Balentine D. A., Harbowy M. E. and Graham H. N.<space/></arg><arg name="title">Tea: the Plant and its Manufacture; Chemistry and Consumption of the Beverage<space/></arg><arg name="journal">Caffeine<space/></arg><arg name="year">1998<space/></arg><arg name="editor">G Spiller</arg></template><template><target>Clarify</target><arg name="date">January 2014</arg><arg name="reason">Which is this—a book or a journal? If a book, which page? If a journal, a link can help verify this.</arg></template></extension><template><target>Clarify</target><arg name="date">January 2014</arg><arg name="reason">Which is this—a book or a journal? If a book, which page? If a journal, a link can help verify this.</arg></template></paragraph><heading level='2'>Products</heading><paragraph><template><target>see also</target><arg>Caffeinated drink</arg></template></paragraph><table class="sortable wikitable" style="width:35%; float:right; clear:right; margin:0 0 0.5em 1em; font-size:85%;"><tablecaption>Caffeine content in select food and drugs<extension extension_name='ref' name="Content"><template><target>cite web</target><arg name="title">Caffeine Content of Food and Drugs<space/></arg><arg name="work">Nutrition Action Health Newsletter<space/></arg><arg name="publisher">[[Center for Science in the Public Interest]]<space/></arg><arg name="year">1996<space/></arg><arg name="url">http://www.cspinet.org/nah/caffeine/caffeine_content.htm<space/></arg><arg name="archiveurl">https://web.archive.org/web/20070614144016/http://www.cspinet.org/nah/caffeine/caffeine_content.htm<space/></arg><arg name="archivedate">14 June 2007<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><extension extension_name='ref' name="Erowid"><template><target>cite web</target><arg name="title">Caffeine Content of Beverages, Foods, & Medications<space/></arg><arg name="publisher">[[Erowid|The Vaults of Erowid]]<space/></arg><arg name="date">7 July 2006<space/></arg><arg name="url">http://www.erowid.org/chemicals/caffeine/caffeine_info1.shtml<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.caffeineinformer.com/the-caffeine-database<space/></arg><arg name="title">Caffeine Content of Drinks<space/></arg><arg name="work">Caffeine Informer<space/></arg><arg name="accessdate">8 December 2013</arg></template></extension><extension extension_name='ref' name="JAT"></extension><extension extension_name='ref' name="Richardson"></extension><xhtml:br></xhtml:br></tablecaption><tablerow><tablehead>Product</tablehead><tablehead style="width:26%;">Serving size</tablehead><tablehead style="width:12%;">Caffeine per serving (<link><target>milligrams</target><part>mg</part></link>)</tablehead><tablehead style="width:12%;">Caffeine (mg/<link><target>litre</target><part>L</part></link>)</tablehead></tablerow><tablerow><tablecell>Caffeine tablet (regular-strength)</tablecell><tablecell>1 tablet</tablecell><tablecell><template><target>Nts</target><arg>100</arg></template></tablecell><tablecell></tablecell></tablerow><tablerow><tablecell>Caffeine tablet (extra-strength)</tablecell><tablecell>1 tablet</tablecell><tablecell><template><target>Nts</target><arg>200</arg></template></tablecell><tablecell></tablecell></tablerow><tablerow><tablecell><link><target>Excedrin</target></link><space/>tablet</tablecell><tablecell>1 tablet</tablecell><tablecell><template><target>Nts</target><arg>65</arg></template></tablecell><tablecell></tablecell></tablerow><tablerow><tablecell><link><target>Hershey's Special Dark</target></link><space/>(45% cacao content)</tablecell><tablecell><template><target>nowrap</target><arg name="1 bar ({{convert|43|g|oz|abbr">on|disp</arg></template></tablecell><tablecell><template><target>Nts</target><arg>31</arg></template></tablecell><tablecell></tablecell></tablerow><tablerow><tablecell><link><target>Hershey's Milk Chocolate</target></link><space/>(11% cacao content)</tablecell><tablecell><template><target>nowrap</target><arg name="1 bar ({{convert|43|g|oz|abbr">on|disp</arg></template></tablecell><tablecell><template><target>Nts</target><arg>10</arg></template></tablecell><tablecell></tablecell></tablerow><tablerow><tablecell><link><target>coffee percolator</target><part>Percolated</part></link><space/><link><target>coffee</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|207|mL|USfloz|abbr">on|link</arg></template></tablecell><tablecell><template><target>Nts</target><arg>80</arg></template>135</tablecell><tablecell><template><target>Nts</target><arg>386</arg></template>652</tablecell></tablerow><tablerow><tablecell><link><target>drip brew</target><part>Drip</part></link><space/>coffee</tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|207|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>115</arg></template>175</tablecell><tablecell><template><target>Nts</target><arg>555</arg></template>845</tablecell></tablerow><tablerow><tablecell><template><target>nowrap</target><arg>Coffee, [[decaffeinated]]</arg></template></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|207|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>5</arg></template>15</tablecell><tablecell><template><target>Nts</target><arg>24</arg></template>72</tablecell></tablerow><tablerow><tablecell>Coffee,<space/><link><target>espresso</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|44|–|60|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>100</arg></template></tablecell><tablecell><template><target>Nts</target><arg>1691</arg></template>2,254</tablecell></tablerow><tablerow><tablecell><link><target>Tea</target></link>&amp;nbsp; black, green, and other<space/><link><target>Tea#Processing and classification</target><part>types</part></link>,&amp;nbsp; steeped for 3 min.</tablecell><tablecell><template><target>nowrap</target><arg>{{convert|177|mL|USfloz}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>22</arg></template>74<extension extension_name='ref' name="JAT"><template><target>cite journal</target><arg name="author"><space/>Chin JM, Merves ML, Goldberger BA, Sampson-Cone A, Cone EJ<space/></arg><arg name="title"><space/>Caffeine content of brewed teas<space/></arg><arg name="journal"><space/>J Anal Toxicol<space/></arg><arg name="volume"><space/>32<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>702–4<space/></arg><arg name="date"><space/>October 2008<space/></arg><arg name="pmid"><space/>19007524<space/></arg><arg name="doi"><space/>10.1093/jat/32.8.702<space/></arg></template></extension><extension extension_name='ref' name="Richardson"><template><target>cite web</target><arg name="url">http://www.elmwoodinn.com/about/caffeine.html<space/></arg><arg name="title">Too Easy to be True. De-bunking the At-Home Decaffeination Myth<space/></arg><arg name="last">Richardson<space/></arg><arg name="first">Bruce<space/></arg><arg name="year">2009<space/></arg><arg name="publisher">Elmwood Inn<space/></arg><arg name="accessdate">12 January 2012</arg></template></extension></tablecell><tablecell><template><target>Nts</target><arg>124</arg></template>418</tablecell></tablerow><tablerow><tablecell>Guayak<space/><link><target>mate (beverage)</target><part>yerba mate</part></link><space/>(loose leaf)</tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|6|g|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>85</arg></template><extension extension_name='ref' name="Guayak"><template><target>cite web</target><arg name="title">Traditional Yerba Mate in Biodegradable Bag<space/></arg><arg name="publisher">Guayaki Yerba Mate<space/></arg><arg name="url">http://guayaki.com/product/41/Traditional-Yerba-Mate-%5B1-lb.%5D.html<space/></arg><arg name="accessdate">17 July 2010</arg></template></extension></tablecell><tablecell><template><target>Nts</target><arg>358</arg><arg name="prefix">approx.&nbsp;</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Coca-Cola</target></link><space/>Classic</tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|355|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>34</arg></template></tablecell><tablecell><template><target>Nts</target><arg>96</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Mountain Dew</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|355|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>54</arg></template></tablecell><tablecell><template><target>Nts</target><arg>154</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Pepsi Max (North America)</target><part>Pepsi Max</part></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|355|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>69</arg></template></tablecell><tablecell><template><target>Nts</target><arg>194</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Guaran Antarctica</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|350|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>30</arg></template></tablecell><tablecell><template><target>Nts</target><arg>100</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Jolt Cola</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|695|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>280</arg></template></tablecell><tablecell><template><target>Nts</target><arg>403</arg></template></tablecell></tablerow><tablerow><tablecell><link><target>Red Bull</target></link></tablecell><tablecell><template><target>nowrap</target><arg name="{{convert|250|mL|USfloz|abbr">on}}</arg></template></tablecell><tablecell><template><target>Nts</target><arg>80</arg></template></tablecell><tablecell><template><target>Nts</target><arg>320</arg></template></tablecell></tablerow></table><paragraph>Products containing caffeine are coffee, tea, soft drinks (&quot;colas&quot;),<space/><link><target>energy drinks</target></link>, other beverages,<space/><link><target>chocolate</target></link>,<extension extension_name='ref' name="Matissek R 1997 17584"><template><target>cite journal</target><arg name="author">Matissek R<space/></arg><arg name="title">Evaluation of xanthine derivatives in chocolate: nutritional and chemical aspects<space/></arg><arg name="id">{{INIST|2861730}}<space/></arg><arg name="journal">European Food Research and Technology<space/></arg><arg name="volume">205<space/></arg><arg name="issue">3<space/></arg><arg name="pages">175–84<space/></arg><arg name="year">1997<space/></arg><arg name="doi">10.1007/s002170050148</arg></template></extension><space/>caffeine tablets, other oral products, and inhalation.</paragraph><heading level='3'>Beverages</heading><heading level='4'>Coffee</heading><paragraph>The world's primary source of caffeine is the coffee &quot;bean&quot; (which is the seed of the<space/><link><target>coffea</target><part>coffee plant</part></link>), from which coffee is brewed. Caffeine content in coffee varies widely depending on the type of<space/><link><target>coffee bean</target></link><space/>and the method of preparation used;<extension extension_name='ref' name="ICO"><template><target>cite web</target><arg name="title">Caffeine<space/></arg><arg name="publisher">International Coffee Organization<space/></arg><arg name="url">http://www.ico.org/caffeine.asp<space/></arg><arg name="accessdate">1 August 2009</arg></template></extension><space/>even beans within a given bush can show variations in concentration. In general, one serving of coffee ranges from 80 to 100 milligrams, for a single shot (30 milliliters) of arabica-variety<space/><link><target>espresso</target></link>, to approximately 100125 milligrams for a cup (120 milliliters) of<space/><link><target>drip coffee</target></link>.<extension extension_name='ref' name="caffaq_roast"><template><target>cite web</target><arg name="title">Coffee and Caffeine FAQ: Does dark roast coffee have less caffeine than light roast?<space/></arg><arg name="url">http://coffeefaq.com/site/node/15<space/></arg><arg name="accessdate">2 August 2009</arg></template></extension><extension extension_name='ref' name="jeremiahspick"><template><target>cite web</target><arg name="title">All About Coffee: Caffeine Level<space/></arg><arg name="publisher">Jeremiah's Pick Coffee Co<space/></arg><arg name="url">http://www.jeremiahspick.com/caffeine-e-13.html<space/></arg><arg name="archiveurl">https://web.archive.org/web/20080318102343/http://www.jeremiahspick.com/caffeine-e-13.html<space/></arg><arg name="archivedate">18 March 2008<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension><space/><italics><link><target>coffea arabica</target><part>Arabica</part></link></italics><space/>coffee typically contains half the caffeine of the<space/><italics><link><target>coffea canephora</target><part>robusta</part></link></italics><space/>variety.<extension extension_name='ref' name="ICO"></extension>In general, dark-roast coffee has very slightly less caffeine than lighter roasts because the roasting process reduces caffeine content of the bean by a small amount.<extension extension_name='ref' name="caffaq_roast"></extension><extension extension_name='ref' name="jeremiahspick"></extension></paragraph><heading level='4'>Tea</heading><paragraph>Tea contains more caffeine than coffee by dry weight. A typical serving, however, contains much less, since tea is normally brewed more weakly than coffee. Also contributing to caffeine content are growing conditions, processing techniques, and other variables. Thus, certain types of tea may contain somewhat more caffeine than other teas.<extension extension_name='ref' name="FRI"><template><target>cite journal</target><arg name="author">Hicks MB, Hsieh Y-H P, Bell LN<space/></arg><arg name="title">Tea preparation and its influence on methylxanthine concentration<space/></arg><arg name="journal">Food Research International<space/></arg><arg name="year">1996<space/></arg><arg name="volume">29<space/></arg><arg name="pages">325–330<space/></arg><arg name="doi">10.1016/0963-9969(96)00038-5<space/></arg><arg name="issue">3–4</arg></template></extension></paragraph><paragraph>Tea contains small amounts of<space/><link><target>theobromine</target></link><space/>and slightly higher levels of<space/><link><target>theophylline</target></link><space/>than coffee. Preparation and many other factors have a significant impact on tea, and color is a very poor indicator of caffeine content. Teas like the pale Japanese<space/><link><target>green tea</target></link>,<space/><italics><link><target>gyokuro</target></link></italics>, for example, contain far more caffeine than much darker teas like<space/><italics><link><target>lapsang souchong</target></link></italics>, which has very little.<extension extension_name='ref' name="FRI"></extension></paragraph><heading level='4'>Soft drinks and energy drinks</heading><paragraph>Caffeine is also a common ingredient of<space/><link><target>soft drink</target><trail>s</trail></link>, such as<space/><link><target>cola</target></link>, originally prepared from<space/><link><target>kola nut</target><trail>s</trail></link>. Soft drinks typically contain 10 to 69 milligrams of caffeine per 12 ounce serving.<template><target>citation needed</target><arg name="date">February 2015</arg></template><space/>By contrast,<space/><link><target>energy drink</target><trail>s</trail></link>, such as<space/><link><target>Red Bull</target></link>, can start at 80 milligrams of caffeine per serving. The caffeine in these drinks either originates from the ingredients used or is an additive derived from the product of<space/><link><target>decaffeination</target></link><space/>or from chemical synthesis. Guarana, a prime ingredient of energy drinks, contains large amounts of caffeine with small amounts of theobromine and theophylline in a naturally occurring<space/><link><target>slow-release</target></link><space/><link><target>excipient</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Bempong DK, Houghton PJ, Steadman K<space/></arg><arg name="year">1993<space/></arg><arg name="title">The xanthine content of guarana and its preparations<space/></arg><arg name="journal">Int J Pharmacog<space/></arg><arg name="issn">0925-1618<space/></arg><arg name="volume">31<space/></arg><arg name="issue">3<space/></arg><arg name="pages">175–181<space/></arg><arg name="doi">10.3109/13880209309082937</arg></template></extension></paragraph><heading level='4'>Other beverages</heading><list type='bullet'><listitem><link><target>Mate (beverage)</target><part>Mate</part></link><space/>is a drink popular in many parts of South America. Its preparation consists of filling a gourd with the leaves of the South American holly<space/><link><target>yerba mate</target></link>, pouring hot but not boiling water over the leaves, and drinking with a straw, the bombilla, which acts as a filter so as to draw only the liquid and not the yerba leaves.<template><target>citation needed</target><arg name="date">January 2015</arg></template><space/></listitem><listitem><link><target>Guaran</target></link><space/>seeds (&quot;beans&quot;) are used in making the commercially sold beverage<space/><link><target>Guaran Antarctica</target></link>, which originated in Brazil and is currently the fifteenth most popular soft drink in the world.<template><target>citation needed</target><arg name="date">January 2015</arg></template></listitem><listitem>The leaves of<space/><link><target>Ilex guayusa</target></link>, the Equadorian holly tree, are placed in boiling water to make a guayusa tea, which is both brewed locally and sold commercially throughout the world.<template><target>citation needed</target><arg name="date">January 2015</arg></template></listitem></list><heading level='3'>Chocolate</heading><paragraph><link><target>Chocolate</target></link><space/>derived from cocoa beans contains a small amount of caffeine. The weak stimulant effect of chocolate may be due to a combination of theobromine and theophylline, as well as caffeine.<extension extension_name='ref' name="pmid15549276"><template><target>cite journal</target><arg name="author"><space/>Smit HJ, Gaffan EA, Rogers PJ<space/></arg><arg name="title"><space/>Methylxanthines are the psycho-pharmacologically active constituents of chocolate<space/></arg><arg name="journal"><space/>Psychopharmacology (Berl.)<space/></arg><arg name="volume"><space/>176<space/></arg><arg name="issue"><space/>3–4<space/></arg><arg name="pages"><space/>412–9<space/></arg><arg name="date"><space/>November 2004<space/></arg><arg name="pmid"><space/>15549276<space/></arg><arg name="doi"><space/>10.1007/s00213-004-1898-3<space/></arg></template></extension><space/>A typical 28-gram serving of a milk<space/><link><target>chocolate bar</target></link><space/>has about as much caffeine as a cup of decaffeinated coffee. By weight,<space/><link><target>dark chocolate</target></link><space/>has one to two times the amount caffeine as coffee: 80160&amp;nbsp;mg per 100&amp;nbsp;g.<extension extension_name='ref' name="Erowid"></extension></paragraph><heading level='3'>Tablets</heading><paragraph><link><target>File:No-Doz.jpg</target><part>thumb</part><part>right</part><part>No-Doz 100 mg caffeine tablets</part></link>Tablets offer the advantages over coffee and tea of convenience, known dosage, and avoiding concomitant fluid intake. Manufacturers of caffeine tablets claim that using caffeine of pharmaceutical quality improves mental alertness.<template><target>citation needed</target><arg name="date">December 2014</arg></template><space/>These tablets are commonly used by students studying for their exams and by people who work or drive for long hours.<extension extension_name='ref'><template><target>cite book</target><arg name="url">http://books.google.com/?id</arg><arg name="page">195<space/></arg><arg name="title">The World of caffeine: The Science and Culture of the World's Most Popular Drug<space/></arg><arg name="author">Bennett Alan Weinberg, Bonnie K. Bealer<space/></arg><arg name="publisher">Routledge<space/></arg><arg name="year">2001<space/></arg><arg name="isbn">978-0-415-92723-9<space/></arg><arg name="accessdate">15 January 2014</arg></template></extension></paragraph><heading level='3'>Other oral products</heading><paragraph>One U.S. company is marketing oral dissolvable caffeine strips.<extension extension_name='ref'><template><target>cite news</target><arg name="url">http://abcnews.go.com/Health/lebron-james-shills-sheets-caffeine-strips-bad-idea/story?id</arg><arg name="title">LeBron James Shills for Sheets Caffeine Strips, a Bad Idea for Teens, Experts Say<space/></arg><arg name="publisher">ABC News<space/></arg><arg name="website">Abcnews.go.com<space/></arg><arg name="date">10 June 2011<space/></arg><arg name="accessdate">25 May 2012</arg></template></extension><space/>Another intake route is<space/><link><target>SpazzStick</target></link>, a caffeinated<space/><link><target>lip balm</target></link>.<extension extension_name='ref'><template><target>cite news</target><arg name="author">Nancy Shute<space/></arg><arg name="url">http://health.usnews.com/usnews/health/articles/070415/23caffeine_6.htm<space/></arg><arg name="title">Over The Limit:Americans young and old crave high-octane fuel, and doctors are jittery<space/></arg><arg name="publisher">US News and World Reports<space/></arg><arg name="date">15 April 2007<space/></arg><arg name="deadurl">yes<space/></arg><arg name="archiveurl">https://web.archive.org/20140108071216/http://health.usnews.com/usnews/health/articles/070415/23caffeine_6.htm<space/></arg><arg name="archivedate">8 January 2014<space/></arg></template></extension><space/>Alert Energy Caffeine Gum was introduced in the United States in 2013, but was voluntarily withdrawn after an announcement of an investigation by the FDA of the health effects of added caffeine in foods.<extension extension_name='ref' name="NYT5813"><template><target>cite news</target><arg name="title">F.D.A. Inquiry Leads Wrigley to Halt ‘Energy Gum’ Sales<space/></arg><arg name="url">http://www.nytimes.com/2013/05/09/business/fda-inquiry-leads-wrigley-to-halt-energy-gum-sales.html<space/></arg><arg name="accessdate">9 May 2013<space/></arg><arg name="newspaper">New York Times<space/></arg><arg name="date">8 May 2013<space/></arg><arg name="agency">Associated Press</arg></template></extension></paragraph><heading level='3'>Inhalants</heading><paragraph>Taking caffeine by inhalation was under scrutiny by some U.S. lawmakers in 2011.<extension extension_name='ref'>http://www.washingtonpost.com/business/controversy-over-inhaled-caffeine-grows-as-as-sen-schumer-calls-for-fda-probe/2011/12/22/gIQAjQaVDP_story.html<template><target>dead link</target><arg name="date">March 2014</arg></template></extension></paragraph><heading level='3'>Combinations with other drugs</heading><list type='bullet'><listitem>Some beverages combine<space/><link><target>ethanol</target><part>alcohol</part></link><space/>with caffeine to create a<space/><link><target>caffeinated alcoholic drink</target></link>. The stimulant effects of caffeine may mask the<space/><link><target>depressant</target></link><space/>effects of alcohol, potentially reducing the user's awareness of their level of<space/><link><target>Alcohol intoxication</target><part>intoxication</part></link>. Such beverages have been the subject of<space/><link><target>Ban on caffeinated alcoholic beverages</target><part>bans</part></link><space/>due to safety concerns. In particular,<space/><link><target>United States Food and Drug Administration</target></link><space/>has classified caffeine added to malt liquor beverages as an &quot;unsafe food additive&quot;.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ucm190366.htm</arg><arg name="title">Food Additives & Ingredients ><space/>Caffeinated Alcoholic Beverages</arg><arg name="date">17 November 2010</arg><arg name="website">fda.gov</arg><arg name="publisher">Food and Drug Administration</arg><arg name="accessdate">24 January 2014</arg></template></extension></listitem><listitem><link><target>Ya ba</target></link><space/>contains a combination of<space/><link><target>methamphetamine</target></link><space/>and caffeine.</listitem></list><heading level='2'>Decaffeination</heading><paragraph><template><target>Main</target><arg>Decaffeination</arg></template><link><target>File:CaffeineCrystals Fibrous 10xDarkField.jpg</target><part>thumb</part><part>250px</part><part>Fibrous<space/><link><target>crystal</target><trail>s</trail></link><space/>of purified caffeine.<space/><link><target>Dark field</target></link><space/><link><target>light microscope</target></link><space/>image, the image covers an area of approx. 7 x 11mm.</part></link></paragraph><paragraph>Extraction of caffeine from coffee, to produce caffeine and decaffeinated coffee, can be performed using a number of solvents.<space/><link><target>Benzene</target></link>,<space/><link><target>chloroform</target></link>,<space/><link><target>trichloroethylene</target></link>, and<space/><link><target>dichloromethane</target></link><space/>have all been used over the years but for reasons of safety, environmental impact, cost, and flavor, they have been superseded by the following main methods:</paragraph><list type='bullet'><listitem><bold>Water extraction:</bold><space/>Coffee beans are soaked in water. The water, which contains many other compounds in addition to caffeine and contributes to the flavor of coffee, is then passed through<space/><link><target>Activated carbon</target><part>activated charcoal</part></link>, which removes the caffeine. The water can then be put back with the beans and evaporated dry, leaving decaffeinated coffee with its original flavor. Coffee manufacturers recover the caffeine and resell it for use in soft drinks and over-the-counter caffeine tablets.<extension extension_name='ref' name="Decaffeination"><template><target>cite web</target><arg name="author">Senese F<space/></arg><arg name="title">How is coffee decaffeinated?<space/></arg><arg name="publisher">General Chemistry Online<space/></arg><arg name="date">20 September 2005<space/></arg><arg name="url">http://antoine.frostburg.edu/chem/senese/101/consumer/faq/decaffeinating-coffee.shtml<space/></arg><arg name="accessdate">3 August 2009</arg></template></extension></listitem><listitem><bold>Supercritical carbon dioxide extraction:</bold><space/><link><target>Supercritical carbon dioxide</target></link><space/>is an excellent nonpolar solvent for caffeine, and is safer than the organic solvents that are otherwise used. The extraction process is simple:<space/><template><target>CO2</target></template><space/>is forced through the green coffee beans at temperatures above 31.1&amp;nbsp;C and pressures above 73<space/><link><target>Atmosphere (unit)</target><part>atm</part></link>. Under these conditions,<space/><template><target>CO2</target></template><space/>is in a &quot;<link><target>Supercritical fluid</target><part>supercritical</part></link>&quot;<space/><link><target>Phase (matter)</target><part>state</part></link>: It has gaslike properties that allow it to penetrate deep into the beans but also liquid-like properties that dissolve 9799% of the caffeine. The caffeine-laden<space/><template><target>CO2</target></template><space/>is then sprayed with high pressure water to remove the caffeine. The caffeine can then be isolated by<space/><link><target>Activated carbon</target><part>charcoal</part></link><space/><link><target>adsorption</target></link><space/>(as above) or by<space/><link><target>distillation</target></link>,<space/><link><target>Recrystallization (chemistry)</target><part>recrystallization</part></link>, or<space/><link><target>reverse osmosis</target></link>.<extension extension_name='ref' name="Decaffeination"></extension></listitem><listitem><bold>Extraction by organic solvents:</bold><space/>Certain organic solvents such as<space/><link><target>ethyl acetate</target></link><space/>present much less health and environmental hazard than chlorinated and aromatic organic solvents used formerly. Another method is to use triglyceride oils obtained from spent coffee grounds.<extension extension_name='ref' name="Decaffeination"></extension></listitem></list><paragraph>&quot;Decaffeinated&quot; coffees do in fact contain caffeine in many cases&amp;nbsp; some commercially available decaffeinated coffee products contain considerable levels. One study found that decaffeinated coffee contained 10&amp;nbsp;mg of caffeine per cup, compared to approximately 85&amp;nbsp;mg of caffeine per cup for regular coffee.<extension extension_name='ref' name="pmid17132260"><template><target>cite journal</target><arg name="author"><space/>McCusker RR, Fuehrlein B, Goldberger BA, Gold MS, Cone EJ<space/></arg><arg name="title"><space/>Caffeine content of decaffeinated coffee<space/></arg><arg name="journal"><space/>J Anal Toxicol<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>611–3<space/></arg><arg name="date"><space/>October 2006<space/></arg><arg name="pmid"><space/>17132260<space/></arg><arg name="doi"><space/>10.1093/jat/30.8.611<space/></arg><arg name="laysummary"><space/>http://news.ufl.edu/2006/10/10/decaf/<space/></arg><arg name="laysource"><space/>University of Florida News<space/></arg></template></extension></paragraph><heading level='2'>History</heading><heading level='3'>Discovery and spread of use</heading><paragraph><link><target>File:Kahvihuone.jpg</target><part>thumb</part><part><link><target>Coffeehouse</target></link><space/>in<space/><link><target>Ottoman Palestine</target><part>Palestine</part></link>, circa 1900</part><part>alt=An old photo of a dozen old and middle-aged men sitting on the ground around a mat. A man in front sits next to a mortar and holds a bat, ready for grinding. A man opposite to him holds a long spoon.</part></link><template><target>main</target><arg>History of chocolate</arg><arg>History of coffee</arg><arg>History of tea</arg><arg>History of yerba mate</arg></template></paragraph><paragraph>According to Chinese legend, the<space/><link><target>Emperor of China</target><part>Chinese emperor</part></link><space/><link><target>Shennong</target></link>, reputed to have reigned in about 3000 BCE, accidentally discovered tea when he noted that when certain leaves fell into boiling water, a fragrant and restorative drink resulted.<extension extension_name='ref'><template><target>cite book</target><arg name="author">John C. Evans<space/></arg><arg name="year">1992<space/></arg><arg name="title">Tea in China: The History of China's National Drink<space/></arg><arg name="publisher">Greenwood Press<space/></arg><arg name="isbn">0-313-28049-5<space/></arg><arg name="page">2</arg></template></extension><space/>Shennong is also mentioned in Lu Yu's<space/><italics><link><target>Cha Jing</target></link></italics>, a famous early work on the subject of tea.<extension extension_name='ref'><template><target>cite book</target><arg name="author">Yu L<space/></arg><arg name="title">The Classic of Tea: Origins & Rituals<space/></arg><arg name="publisher">Ecco Pr<space/></arg><arg name="year">1995<space/></arg><arg name="isbn">0-88001-416-4</arg></template><template><target>page needed</target><arg name="date">January 2014</arg></template></extension></paragraph><paragraph>The earliest credible evidence of either coffee drinking or knowledge of the coffee tree appears in the middle of the fifteenth century, in the<space/><link><target>Sufi</target></link><space/>monasteries of the<space/><link><target>Yemen</target><trail>in</trail></link><space/>southern Arabia.<extension extension_name='ref' name="Bennett"><template><target>cite book</target><arg name="author">Bennett Alan Weinberg, Bonnie K. Bealer<space/></arg><arg name="title">The World of Caffeine: The Science and Culture of the World's Most Popular Drug<space/></arg><arg name="year">2001<space/></arg><arg name="pages">3–4<space/></arg><arg name="isbn">978-0-415-92723-9<space/></arg><arg name="publisher">Routledge</arg></template></extension><space/>From<space/><link><target>Mokha</target><part>Mocha</part></link>, coffee spread to<space/><link><target>Mameluke Sultanate</target><part>Egypt</part></link><space/>and North Africa, and by the 16th century, it had reached the rest of the Middle East,<space/><link><target>Safavid Empire</target><part>Persia</part></link><space/>and<space/><link><target>Ottoman Empire</target><part>Turkey</part></link>. From the Middle East, coffee drinking spread to Italy, then to the rest of Europe, and coffee plants were transported by the Dutch to the<space/><link><target>East Indies</target></link><space/>and to the Americas.<extension extension_name='ref' name="Meyers"><template><target>cite web</target><arg name="last">Meyers<space/></arg><arg name="first">Hannah<space/></arg><arg name="title">"Suave Molecules of Mocha" – Coffee, Chemistry, and Civilization<space/></arg><arg name="work"><space/></arg><arg name="publisher">New Partisan<space/></arg><arg name="date">7 March 2005<space/></arg><arg name="url">http://www.newpartisan.com/home/suave-molecules-of-mocha-coffee-chemistry-and-civilization.html<space/></arg><arg name="archiveurl">https://web.archive.org/web/20050309110855/http://www.newpartisan.com/home/suave-molecules-of-mocha-coffee-chemistry-and-civilization.html<space/></arg><arg name="archivedate">9 March 2005<space/></arg><arg name="accessdate">3 February 2007</arg></template></extension></paragraph><paragraph><link><target>Kola nut</target></link><space/>use appears to have ancient origins. It is chewed in many<space/><link><target>West Africa</target><trail>n</trail></link><space/>cultures, individually or in a social setting, to restore vitality and ease hunger pangs.</paragraph><paragraph>The earliest evidence of<space/><link><target>cocoa bean</target></link><space/>use comes from residue found in an<space/><link><target>Maya civilization</target><part>ancient Mayan</part></link><space/>pot dated to 600 BCE. Also,<space/><link><target>chocolate</target></link><space/>was consumed in a bitter and spicy drink called<space/><italics>xocolatl</italics>, often seasoned with<space/><link><target>vanilla</target></link>,<space/><link><target>chile pepper</target></link>, and<space/><link><target>achiote</target></link>.<space/><italics>Xocolatl</italics><space/>was believed to fight fatigue, a belief probably attributable to the theobromine and caffeine content. Chocolate was an important luxury good throughout<space/><link><target>pre-Columbian</target></link><space/><link><target>Mesoamerica</target></link>, and cocoa beans were often used as currency.<template><target>citation needed</target><arg name="date">October 2011</arg></template></paragraph><paragraph><italics>Xocolatl</italics><space/>was introduced to<space/><link><target>Europe</target></link><space/>by the<space/><link><target>Spanish people</target><part>Spaniards</part></link>, and became a popular beverage by 1700. The Spaniards also introduced the<space/><link><target>Theobroma cacao</target><part>cacao tree</part></link><space/>into the<space/><link><target>West Indies</target></link><space/>and the<space/><link><target>Philippines</target></link>. It was used in<space/><link><target>alchemy</target><part>alchemical</part></link><space/>processes, where it was known as &quot;black bean&quot;.<template><target>citation needed</target><arg name="date">October 2011</arg></template></paragraph><paragraph>The leaves and stems of the yaupon holly (<italics><link><target>Ilex vomitoria</target></link></italics>) were used by<space/><link><target>Indigenous peoples of the Americas</target><part>Native Americans</part></link><space/>to brew a<space/><link><target>tea</target></link><space/>called<space/><italics>asi</italics><space/>or the &quot;<link><target>black drink</target></link>&quot;.<extension extension_name='ref' name="Fairbanks"><template><target>cite book</target><arg name="author">Fairbanks, Charles H.<space/></arg><arg name="editor">[[Charles M. Hudson (author)|Hudson, Charles M.]]<space/></arg><arg name="title">Black Drink<space/></arg><arg name="publisher">University of Georgia Press<space/></arg><arg name="year">2004<space/></arg><arg name="chapter">The function of black drink among the Creeks<space/></arg><arg name="isbn">978-0-8203-2696-2<space/></arg><arg name="page">123</arg></template></extension><space/>Archaeologists have found evidence of this use far into antiquity,<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Crown PL, Emerson TE, Gu J, Hurst WJ, Pauketat TR, Ward T<space/></arg><arg name="title"><space/>Ritual Black Drink consumption at Cahokia<space/></arg><arg name="journal"><space/>Proc. Natl. Acad. Sci. U.S.A.<space/></arg><arg name="volume"><space/>109<space/></arg><arg name="issue"><space/>35<space/></arg><arg name="pages"><space/>13944–13949<space/></arg><arg name="date"><space/>August 2012<space/></arg><arg name="pmid"><space/>22869743<space/></arg><arg name="pmc"><space/>3435207<space/></arg><arg name="doi"><space/>10.1073/pnas.1208404109<space/></arg><arg name="url"><space/>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435207/<space/></arg></template></extension><space/>possibly dating to<space/><link><target>Archaic period in the Americas</target><part>Late Archaic times</part></link>.<extension extension_name='ref' name="Fairbanks"></extension></paragraph><heading level='3'>Chemical identification, isolation, and synthesis</heading><paragraph><link><target>File:Pierre Joseph Pelletier.jpg</target><part>thumb</part><part>upright</part><part>Pierre Joseph Pelletier</part></link>In 1819, the German chemist<space/><link><target>Friedlieb Ferdinand Runge</target></link><space/>isolated relatively pure caffeine for the first time; he called it<space/><italics>&quot;Kaffebase&quot;</italics><space/>(i.e. a<space/><link><target>base (chemistry)</target><part>base</part></link><space/>that exists in coffee).<extension extension_name='ref'><template><target>cite book</target><arg name="last">Runge<space/></arg><arg name="first">Friedlieb Ferdinand<space/></arg><arg name="title">Neueste phytochemische Entdeckungen zur Begründung einer wissenschaftlichen Phytochemie<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="year">1820<space/></arg><arg name="publisher">G. Reimer<space/></arg><arg name="location">Berlin<space/></arg><arg name="pages">144–159<space/></arg><arg name="trans_title">Latest phytochemical discoveries for the founding of a scientific phytochemistry<space/></arg><arg name="accessdate">8 January 2014</arg></template></extension><space/>According to Runge, he did this at the behest of<space/><link><target>Johann Wolfgang von Goethe</target></link>.<extension extension_name='ref'>In 1819, Runge was invited to show Goethe how belladonna caused dilation of the pupil, which Runge did, using a cat as an experimental subject. Goethe was so impressed with the demonstration that:<space/><italics>&quot;Nachdem Goethe mir seine grte Zufriedenheit sowol ber die Erzhlung des durch scheinbaren schwarzen Staar Geretteten, wie auch ber das andere ausgesprochen, bergab er mir noch eine Schachtel mit Kaffeebohnen, die ein Grieche ihm als etwas Vorzgliches gesandt. &quot;Auch diese knnen Sie zu Ihren Untersuchungen brauchen,&quot; sagte Goethe. Er hatte recht; denn bald darauf entdeckte ich darin das, wegen seines groen Stickstoffgehaltes so berhmt gewordene Coffein.&quot;</italics><space/>(After Goethe had expressed to me his greatest satisfaction regarding the account of the man [whom I'd] rescued [from serving in Napoleon's army] by apparent &quot;black star&quot; [i.e., amaurosis, blindness] as well as the other, he handed me a carton of coffee beans, which a Greek had sent him as a delicacy. &quot;You can also use these in your investigations,&quot; said Goethe. He was right; for soon thereafter I discovered therein caffeine, which became so famous on account of its high nitrogen content.)<xhtml:br></xhtml:br>This account appeared in Runge's book<space/><italics>Hauswirtschaftlichen Briefen</italics><space/>(Domestic Letters [i.e., personal correspondence]) of 1866. It was reprinted in: Johann Wolfgang von Goethe with F.W. von Biedermann, ed.,<space/><italics>Goethes Gesprche</italics>, vol. 10:<space/><italics>Nachtrge, 17551832</italics><space/>(Leipzig, (Germany): F.W. v. Biedermann, 1896), pages 8996; see especially<space/><link type='external' href='http://books.google.com/books?id=MacwAAAAYAAJ&amp;amp;pg=PA95'>page 95</link>.</extension><extension extension_name='ref' name="weinberg"><template><target>cite book</target><arg name="author">Bennett Alan Weinberg, Bonnie K. Bealer<space/></arg><arg name="title">The World of Caffeine: The Science and Culture of the World's Most Popular Drug<space/></arg><arg name="publisher">Routledge<space/></arg><arg name="year">2001<space/></arg><arg name="isbn">978-0-415-92723-9</arg></template><template><target>page needed</target><arg name="date">January 2014</arg></template></extension><space/>In 1821, caffeine was isolated both by the French chemist<space/><link><target>Pierre Jean Robiquet</target></link><space/>and by another pair of French chemists,<space/><link><target>Pierre Joseph Pelletier</target><part>Pierre-Joseph Pelletier</part></link><space/>and<space/><link><target>Joseph Bienaim Caventou</target></link>, according to Swedish chemist<space/><link><target>Jns Jacob Berzelius</target></link><space/>in his yearly journal. Furthermore, Berzelius stated that the French chemists had made their discoveries independently of any knowledge of Runge's or each other's work.<extension extension_name='ref'><template><target>cite journal</target><arg name="year">1825<space/></arg><arg name="title">Jahres-Bericht über die Fortschritte der physischen Wissenschaften von Jacob Berzelius<space/></arg><arg name="volume">4<space/></arg><arg name="page">180<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="language">German<space/></arg><arg name="trans_title">Annual report on the progress of the physical sciences by Jacob Berzelius<space/></arg><arg name="last">Berzelius<space/></arg><arg name="first">Jöns Jakob</arg></template><space/>From page 180:<space/><italics>&quot;Cafin ist eine Materie im Kaffee, die zu gleicher Zeit, 1821, von Robiquet und Pelletier und Caventou entdekt wurde, von denen aber keine etwas darber im Drucke bekannt machte.&quot;</italics><space/>(Caffeine is a material in coffee, which was discovered at the same time, 1821, by Robiquet and [by] Pelletier and Caventou, by whom however nothing was made known about it in the press.)</extension><space/>However, Berzelius later acknowledged Runge's priority in the extraction of caffeine, stating:<extension extension_name='ref'><template><target>cite book</target><arg name="title">Jahres-Bericht über die Fortschritte der physischen Wissenschaften von Jacob Berzelius<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="volume">7<space/></arg><arg name="year">1828<space/></arg><arg name="trans_title">Annual Report on the Progress of the Physical Sciences by Jacob Berzelius<space/></arg><arg name="language">German<space/></arg><arg name="page">270<space/></arg><arg name="author">Berzelius JJ</arg></template><space/>From page 270:<space/><italics>&quot;Es darf indessen hierbei nicht unerwhnt bleiben, dass Runge (in seinen phytochemischen Entdeckungen 1820, p. 146-7.) dieselbe Methode angegeben, und das Caffein unter dem Namen<space/></italics>Caffeebase<italics><space/>ein Jahr eher beschrieben hat, als Robiquet, dem die Entdeckung dieser Substanz gewhnlich zugeschrieben wird, in einer Zusammenkunft der Societ de Pharmacie in Paris die erste mndliche Mittheilung darber gab.&quot;</italics><space/>(However, at this point, it should not remain unmentioned that Runge (in his<space/><italics>Phytochemical Discoveries</italics>, 1820, pages 146147) specified the same method and described caffeine under the name<space/><italics>Caffeebase</italics><space/>a year earlier than Robiquet, to whom the discovery of this substance is usually attributed, having made the first oral announcement about it at a meeting of the Pharmacy Society in Paris.)</extension><space/>&quot;However, at this point, it should not remain unmentioned that Runge (in his<space/><italics>Phytochemical Discoveries</italics>, 1820, pages 146147) specified the same method and described caffeine under the name<space/><italics>Caffeebase</italics><space/>a year earlier than Robiquet, to whom the discovery of this substance is usually attributed, having made the first oral announcement about it at a meeting of the Pharmacy Society in Paris.&quot;</paragraph><paragraph>Pelletier's article on caffeine was the first to use the term in print (in the French form<space/><italics>Cafine</italics><space/>from the French word for coffee:<space/><italics>caf</italics>).<extension extension_name='ref'><template><target>cite encyclopedia</target><arg name="last">Pelletier<space/></arg><arg name="first">Pierre Joseph<space/></arg><arg name="authorlink">Pierre Joseph Pelletier<space/></arg><arg name="encyclopedia">Dictionnaire de Médecine<space/></arg><arg name="title">Cafeine<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="accessdate">3 March 2011<space/></arg><arg name="language">French<space/></arg><arg name="year">1822<space/></arg><arg name="publisher">Béchet Jeune<space/></arg><arg name="volume">4<space/></arg><arg name="location">Paris<space/></arg><arg name="pages">35–36</arg></template></extension><space/>It corroborates Berzelius's account:</paragraph><paragraph><template><target>quote</target><arg>Caffeine, noun (feminine). Crystallizable substance discovered in coffee in 1821 by Mr. Robiquet. During the same period&nbsp;– while they were searching for quinine in coffee because coffee is considered by several doctors to be a medicine that reduces fevers and because coffee belongs to the same family as the cinchona [quinine] tree&nbsp;– on their part, Messrs. Pelletier and Caventou obtained caffeine; but because their research had a different goal and because their research had not been finished, they left priority on this subject to Mr. Robiquet. We do not know why Mr. Robiquet has not published the analysis of coffee which he read to the Pharmacy Society. Its publication would have allowed us to make caffeine better known and give us accurate ideas of coffee's composition&nbsp;...</arg></template></paragraph><paragraph>Robiquet was one of the first to isolate and describe the properties of pure caffeine,<extension extension_name='ref'><template><target>cite encyclopedia</target><arg name="last">Robiquet<space/></arg><arg name="first">Pierre Jean<space/></arg><arg name="authorlink">Robiquet<space/></arg><arg name="encyclopedia">Dictionnaire Technologique, ou Nouveau Dictionnaire Universel des Arts et Métiers<space/></arg><arg name="title">Cafe<space/></arg><arg name="url">http://cnum.cnam.fr/CGI/gpage.cgi?p1</arg><arg name="accessdate">3 March 2011<space/></arg><arg name="language">French<space/></arg><arg name="year">1823<space/></arg><arg name="publisher">Thomine et Fortic<space/></arg><arg name="volume">4<space/></arg><arg name="location">Paris<space/></arg><arg name="pages">50–61</arg></template></extension><space/>whereas Pelletier was the first to perform an<space/><link><target>elemental analysis</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Dumas and Pelletier<space/></arg><arg name="year">1823<space/></arg><arg name="language">French<space/></arg><arg name="title">Recherches sur la composition élémentaire et sur quelques propriétés caractéristiques des bases salifiables organiques<space/></arg><arg name="trans_title">Studies into the elemental composition and some characteristic properties of organic bases<space/></arg><arg name="journal">Annales de Chimie et de Physique<space/></arg><arg name="volume">24<space/></arg><arg name="pages">163–191<space/></arg><arg name="url">http://books.google.com/books?id</arg></template></extension></paragraph><paragraph>In 1827, M. Oudry isolated &quot;thine&quot; from tea,<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Oudry M<space/></arg><arg name="journal">Nouvelle bibliothèque médicale<space/></arg><arg name="volume">1<space/></arg><arg name="year">1827<space/></arg><arg name="title">Note sur la Théine<space/></arg><arg name="pages">477–479<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="language">French</arg></template></extension><space/>but it was later proved by<space/><link><target>Gerardus Johannes Mulder</target><part>Mulder</part></link><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Mulder, G. J.<space/></arg><arg name="year">1838<space/></arg><arg name="title">Ueber Theïn und Caffeïn<space/></arg><arg name="volume">15<space/></arg><arg name="journal">Journal für Praktische Chemie<space/></arg><arg name="pages">280–284<space/></arg><arg name="trans_title">Concerning theine and caffeine<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="doi">10.1002/prac.18380150124</arg></template></extension><space/>and by Carl Jobst<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Jobst, Carl<space/></arg><arg name="year">1838<space/></arg><arg name="title">Thein identisch mit Caffein<space/></arg><arg name="trans_title">Theine is identical to caffeine<space/></arg><arg name="journal">Liebig's Annalen der Chemie und Pharmacie<space/></arg><arg name="volume">25<space/></arg><arg name="pages">63–66<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="doi">10.1002/jlac.18380250106</arg></template></extension><space/>that theine was actually caffeine.<extension extension_name='ref' name="weinberg"></extension></paragraph><paragraph>In 1895, German chemist<space/><link><target>Hermann Emil Fischer</target></link><space/>(18521919) first synthesized caffeine from its chemical components (i.e. a &quot;<link><target>total synthesis</target></link>&quot;), and two years later, he also derived the structural formula of the compound.<extension extension_name='ref'><paragraph>Fischer began his studies of caffeine in 1881; however, understanding of the molecule's structure long eluded him. In 1895 he synthesized caffeine, but only in 1897 did he finally fully determine its molecular structure.</paragraph><list type='bullet'><listitem><template><target>cite journal</target><arg name="author">Fischer E<space/></arg><arg name="year">1881<space/></arg><arg name="language">German<space/></arg><arg name="title">Ueber das Caffeïn<space/></arg><arg name="trans_title"><space/>On caffeine<space/></arg><arg name="journal">Berichte der Deutschen chemischen Gesellschaft zu Berlin<space/></arg><arg name="volume">14<space/></arg><arg name="pages">637–644<space/></arg><arg name="url">http://gallica.bnf.fr/ark:/12148/bpt6k90692z/f640.image.langEN<space/></arg><arg name="doi">10.1002/cber.188101401142</arg></template></listitem><listitem><template><target>cite journal</target><arg name="author">Fischer E<space/></arg><arg name="year">1881<space/></arg><arg name="language">German<space/></arg><arg name="title">Ueber das Caffeïn. Zweite Mitteilung<space/></arg><arg name="trans_title"><space/>On caffeine. Second communication.<space/></arg><arg name="journal">Berichte der Deutschen chemischen Gesellschaft zu Berlin<space/></arg><arg name="volume">14<space/></arg><arg name="pages">1905–1915<space/></arg><arg name="url">http://gallica.bnf.fr/ark:/12148/bpt6k906939/f316.image.langEN<space/></arg><arg name="doi">10.1002/cber.18810140283<space/></arg><arg name="issue">2</arg></template></listitem><listitem><template><target>cite journal</target><arg name="author">Fischer E<space/></arg><arg name="year">1882<space/></arg><arg name="language">German<space/></arg><arg name="title">Ueber das Caffeïn. Dritte Mitteilung<space/></arg><arg name="trans_title"><space/>On caffeine. Third communication.<space/></arg><arg name="journal">Berichte der Deutschen chemischen Gesellschaft zu Berlin<space/></arg><arg name="volume">15<space/></arg><arg name="pages">29–33<space/></arg><arg name="url">http://gallica.bnf.fr/ark:/12148/bpt6k90694n/f32.image.langEN<space/></arg><arg name="doi">10.1002/cber.18820150108</arg></template></listitem><listitem><template><target>cite journal</target><arg name="author">Fischer E, Ach L<space/></arg><arg name="year">1895<space/></arg><arg name="language">German<space/></arg><arg name="title">Synthese des Caffeïns<space/></arg><arg name="trans_title"><space/>On caffeine. Third communication.<space/></arg><arg name="journal">Berichte der Deutschen chemischen Gesellschaft zu Berlin<space/></arg><arg name="volume">28<space/></arg><arg name="pages">3135–3143<space/></arg><arg name="url">http://gallica.bnf.fr/ark:/12148/bpt6k907400/f806.image.langEN<space/></arg><arg name="doi">10.1002/cber.189502803156<space/></arg><arg name="issue">3</arg></template></listitem><listitem><template><target>cite journal</target><arg name="author">Fischer E<space/></arg><arg name="year">1897<space/></arg><arg name="language">German<space/></arg><arg name="title">Ueber die Constitution des Caffeïns, Xanthins, Hypoxanthins und verwandter Basen<space/></arg><arg name="trans_title"><space/>On the constitution of caffeine, xanthin, hypoxanthin, and related bases.<space/></arg><arg name="journal">Berichte der Deutschen chemischen Gesellschaft zu Berlin<space/></arg><arg name="volume">30<space/></arg><arg name="pages">549–559<space/></arg><arg name="url">http://gallica.bnf.fr/ark:/12148/bpt6k907462/f553.image.langEN<space/></arg><arg name="doi">10.1002/cber.189703001110</arg></template></listitem></list></extension><space/>This was part of the work for which Fischer was awarded the<space/><link><target>Nobel Prize in Chemistry</target><part>Nobel Prize</part></link><space/>in 1902.<extension extension_name='ref'><template><target>cite web</target><arg name="accessdate">3 August 2009<space/></arg><arg name="url">http://nobelprize.org/nobel_prizes/chemistry/laureates/1902/press.html<space/></arg><arg name="title">Nobel Prize Presentation Speech<space/></arg><arg name="author">Hj. Théel<space/></arg><arg name="year">1902</arg></template></extension></paragraph><heading level='2'>Society and culture</heading><heading level='3'>Consumption</heading><paragraph>Global consumption of caffeine has been estimated at 120,000&amp;nbsp;tonnes per year, making it the world's most popular psychoactive substance. This amounts to one serving of a caffeinated beverage for every person every day.<extension extension_name='ref' name="abc.net"><template><target>cite news</target><arg name="title">What's your poison: caffeine<space/></arg><arg name="publisher">Australian Broadcasting Corporation<space/></arg><arg name="year">1997<space/></arg><arg name="url">http://www.abc.net.au/quantum/poison/caffeine/caffeine.htm<space/></arg><arg name="accessdate">15 January 2014<space/></arg><arg name="author">Geoffrey Burchfield<space/></arg><arg name="editor">Meredith Hopes</arg></template></extension></paragraph><heading level='3'>Governments</heading><paragraph>Because it was recognized that coffee contained some compound that acted as a stimulant, first coffee and later also caffeine has sometimes been subject to regulation. For example, in the 16th century Islamists in Mecca and in the Ottoman Empire made coffee illegal for some classes.<extension extension_name='ref'><template><target>cite book</target><arg name="last">Brown<space/></arg><arg name="first">Daniel W<space/></arg><arg name="title">A new introduction to Islam<space/></arg><arg name="publisher">Wiley-Blackwell<space/></arg><arg name="location">Chichester, West Sussex<space/></arg><arg name="year">2004<space/></arg><arg name="pages">149–51<space/></arg><arg name="isbn">1-4051-5807-7</arg></template></extension><extension extension_name='ref' name="agostonmasters2009"><template><target>cite book</target><arg name="title">Encyclopedia of the Ottoman Empire<space/></arg><arg name="last1">Ágoston<space/></arg><arg name="first1">Gábor<space/></arg><arg name="last2">Masters<space/></arg><arg name="first2">Bruce<space/></arg><arg name="year">2009<space/></arg><arg name="url">http://books.google.com/?id</arg><arg name="isbn">978-1-4381-1025-7<space/></arg><arg name="page">138</arg></template></extension><extension extension_name='ref' name="hopkins2006"><template><target>cite web</target><arg name="url">http://accidentalhedonist.com/food-stories-the-sultans-coffee-prohibition/<space/></arg><arg name="title">Food Stories: The Sultan's Coffee Prohibition<space/></arg><arg name="last">Hopkins<space/></arg><arg name="first">Kate<space/></arg><arg name="date">24 March 2006<space/></arg><arg name="work">Accidental Hedonist<space/></arg><arg name="accessdate">3 January 2010</arg></template></extension><space/><link><target>Charles II of England</target></link><space/>tried to ban it in 1676,<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.uni-giessen.de/gloning/tx/suppress.htm<space/></arg><arg name="title">By the King. A PROCLAMATION FOR THE Suppression of Coffee-Houses<space/></arg><arg name="accessdate">18 March 2012</arg></template></extension><extension extension_name='ref' name="Pendergrast13"><template><target>harvnb</target><arg>Pendergrast</arg><arg>2001</arg><arg name="page">13</arg></template></extension><space/><link><target>Frederick II of Prussia</target></link><space/>banned it in 1777,<extension extension_name='ref' name="Pendergrast11"><template><target>harvnb</target><arg>Pendergrast</arg><arg>2001</arg><arg name="page">11</arg></template></extension><extension extension_name='ref'><template><target>harvnb</target><arg>Bersten</arg><arg>1999</arg><arg name="page">53</arg></template></extension><space/>and coffee was banned in Sweden at various times between 1756 and 1823.</paragraph><paragraph>In 1911, caffeine became the focus of one of the earliest documented health scares, when the US government seized 40 barrels and 20 kegs of<space/><link><target>Coca-Cola</target></link><space/>syrup in<space/><link><target>Chattanooga, Tennessee</target></link>, alleging the caffeine in its drink was &quot;injurious to health&quot;.<extension extension_name='ref' name="pmid2010614"><template><target>cite journal</target><arg name="author"><space/>Benjamin LT, Rogers AM, Rosenbaum A<space/></arg><arg name="title"><space/>Coca-Cola, caffeine, and mental deficiency: Harry Hollingworth and the Chattanooga trial of 1911<space/></arg><arg name="journal"><space/>J Hist Behav Sci<space/></arg><arg name="volume"><space/>27<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>42–55<space/></arg><arg name="year"><space/>1991<space/></arg><arg name="pmid"><space/>2010614<space/></arg><arg name="doi"><space/>10.1002/1520-6696(199101)27:1<42::AID-JHBS2300270105>3.0.CO;2-1<space/></arg></template></extension><space/>Although the judge ruled in favor of Coca-Cola, two bills were introduced to the<space/><link><target>United States House of Representatives</target><part>U.S. House of Representatives</part></link><space/>in 1912 to amend the<space/><link><target>Pure Food and Drug Act</target></link>, adding caffeine to the list of &quot;habit-forming&quot; and &quot;deleterious&quot; substances, which must be listed on a product's label.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.lewrockwell.com/jarvis/jarvis17.html<space/></arg><arg name="title">The Rise and Fall of Cocaine Cola<space/></arg><arg name="website">Lewrockwell.com<space/></arg><arg name="accessdate">25 May 2012</arg></template><template><target>unreliable source?</target><arg name="date">February 2012</arg></template></extension><template><target>unreliable source?</target><arg name="date">February 2012</arg></template><space/>The Food and Drug Administration (FDA) in the United States currently allows only beverages containing less than 0.02% caffeine;[161] but caffeine powder, which is sold as a dietary supplement, is unregulated.[162]</paragraph><heading level='3'>Religions</heading><paragraph>Some<space/><link><target>Seventh-day Adventist Church</target><part>Seventh-day Adventists</part></link>,<space/><link><target>Church of God (Restoration)</target></link><space/>adherents, and<space/><link><target>Christian Scientists</target></link><space/>do not consume caffeine.<template><target>citation needed</target><arg name="date">December 2011</arg></template><space/>Some from these religions believe that one is not supposed to consume a non-medical, psychoactive substance, or believe that one is not supposed to consume a substance that is addictive.<space/><link><target>The Church of Jesus Christ of Latter-day Saints</target></link><space/>has said the following with regard to caffeinated beverages: &quot;With reference to cola drinks, the Church has never officially taken a position on this matter, but the leaders of the Church have advised, and we do now specifically advise, against the use of any drink containing harmful habit-forming drugs under circumstances that would result in acquiring the habit. Any beverage that contains ingredients harmful to the body should be avoided.&quot;<extension extension_name='ref'><template><target>cite book</target><arg name="title">Doctrine and Covenants Student Manual: Religion 324 and 325<space/></arg><arg name="publisher">LDS Church<space/></arg><arg name="location">Salt Lake City<space/></arg><arg name="year">2001<space/></arg><arg name="page">209<space/></arg><arg name="url">http://www.ldsces.org/inst_manuals/dc-in/dc-in-081.htm<space/></arg><arg name="accessdate">15 January 2014</arg></template></extension></paragraph><paragraph><link><target>Gaudiya Vaishnavism</target><part>Gaudiya Vaishnavas</part></link><space/>generally also abstain from caffeine, because they believe it clouds the mind and over-stimulates the senses. To be initiated under a guru, one must have had no caffeine, alcohol, nicotine or other drugs, for at least a year.<template><target>citation needed</target><arg name="date">September 2011</arg></template></paragraph><paragraph>Caffeinated beverages are widely consumed by<space/><link><target>Muslims</target></link><space/>today. In the 16th century, some Muslim authorities made unsuccessful attempts to ban them as forbidden &quot;intoxicating beverages&quot; under<space/><link><target>Islamic dietary laws</target></link>.<extension extension_name='ref' name="Campo2009"><template><target>cite book</target><arg name="author">Juan Eduardo Campo<space/></arg><arg name="title">Encyclopedia of Islam<space/></arg><arg name="url">http://books.google.com/books?id</arg><arg name="accessdate">1 November 2012<space/></arg><arg name="date">1 January 2009<space/></arg><arg name="publisher">Infobase Publishing<space/></arg><arg name="isbn">978-1-4381-2696-8<space/></arg><arg name="page">154</arg></template></extension><extension extension_name='ref' name="Brown2011"><template><target>cite book</target><arg name="author">Daniel W. Brown<space/></arg><arg name="title">A New Introduction to Islam<space/></arg><arg name="date">24 August 2011<space/></arg><arg name="publisher">John Wiley & Sons<space/></arg><arg name="isbn">978-1-4443-5772-1<space/></arg><arg name="page">149</arg></template></extension></paragraph><heading level='2'>Other organisms</heading><paragraph><link><target>File:Caffeinated spiderwebs modified.jpg</target><part>thumb</part><part>200px</part><part>Caffeine effects on<space/><link><target>spider web</target><trail>s</trail></link></part><part>alt=Caffeine effects on spider webs.</part></link><template><target>See also</target><arg>Effect of psychoactive drugs on animals</arg></template></paragraph><paragraph><italics><link><target>Pseudomonas putida</target></link></italics><space/>CBB5 can live on pure caffeine, and can cleave caffeine into carbon dioxide and ammonia.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://blogs.scientificamerican.com/observations/2011/05/24/newly-discovered-bacteria-lives-on-caffeine<space/></arg><arg name="title">Newly Discovered Bacteria Lives on Caffeine<space/></arg><arg name="work">Blogs.scientificamerican.com<space/></arg><arg name="date">24 May 2011<space/></arg><arg name="accessdate">19 December 2013</arg></template></extension></paragraph><paragraph>Caffeine is toxic to birds<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.multiscope.com/hotspot/caffeine.htm<space/></arg><arg name="title">Why Caffeine is Toxic to Birds<space/></arg><arg name="last">Paul<space/></arg><arg name="first">Dr. Lisa<space/></arg><arg name="work">HotSpot for Birds<space/></arg><arg name="publisher">Advin Systems<space/></arg><arg name="accessdate">29 February 2012</arg></template></extension><space/>and to dogs and cats,<extension extension_name='ref'><template><target>cite web</target><arg name="title">Caffeine</arg><arg name="url">http://www.petpoisonhelpline.com/poison/caffeine/</arg><arg name="accessdate">12 September 2014</arg></template></extension><space/>and has a pronounced adverse effect on<space/><link><target>mollusk</target><trail>s</trail></link>, various insects, and<space/><link><target>spider</target><trail>s</trail></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Noever R, Cronise J, Relwani RA<space/></arg><arg name="title">Using spider-web patterns to determine toxicity<space/></arg><arg name="journal">NASA Tech Briefs<space/></arg><arg name="volume">19<space/></arg><arg name="issue">4<space/></arg><arg name="page">82</arg><arg name="url">http://www.newscientist.com/article/mg14619750.500-spiders-on-speed-get-weaving.html<space/></arg><arg name="publisher">New Scientist magazine<space/></arg><arg name="date">29 April 1995</arg></template></extension><space/>This is at least partly due to a poor ability to metabolize the compound, causing higher levels for a given dose per unit weight.<extension extension_name='ref' name="pmid20859793"><template><target>cite journal</target><arg name="author"><space/>Arnaud MJ<space/></arg><arg name="title"><space/>Pharmacokinetics and metabolism of natural methylxanthines in animal and man<space/></arg><arg name="journal"><space/>Handb Exp Pharmacol<space/></arg><arg name="issue"><space/>200<space/></arg><arg name="pages"><space/>33–91<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>20859793<space/></arg><arg name="doi"><space/>10.1007/978-3-642-13443-2_3<space/></arg><arg name="isbn"><space/>978-3-642-13442-5<space/></arg><arg name="series"><space/>Handbook of Experimental Pharmacology<space/></arg></template></extension><space/>Caffeine has also been found to enhance the reward memory of honeybees, improving the reproductive success of the pollen producing plants.<extension extension_name='ref' name="pmid23471406"><template><target>cite journal</target><arg name="author"><space/>Wright GA, Baker DD, Palmer MJ, Stabler D, Mustard JA, Power EF, Borland AM, Stevenson PC<space/></arg><arg name="title"><space/>Caffeine in floral nectar enhances a pollinator's memory of reward<space/></arg><arg name="journal"><space/>Science<space/></arg><arg name="volume"><space/>339<space/></arg><arg name="issue"><space/>6124<space/></arg><arg name="pages"><space/>1202–4<space/></arg><arg name="date"><space/>March 2013<space/></arg><arg name="pmid"><space/>23471406<space/></arg><arg name="doi"><space/>10.1126/science.1228806<space/></arg></template></extension></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target><arg>30em</arg></template></paragraph><heading level='2'>Bibliography</heading><list type='bullet'><listitem><template><target>cite book</target><arg name="last">Bersten<space/></arg><arg name="first">Ian<space/></arg><arg name="title">Coffee, Sex & Health: A history of anti-coffee crusaders and sexual hysteria<space/></arg><arg name="publisher">Helian Books<space/></arg><arg name="year">1999<space/></arg><arg name="location">Sydney<space/></arg><arg name="isbn">0-9577581-0-3<space/></arg><arg name="ref">CITEREFBersten1999</arg></template></listitem><listitem><template><target>cite book</target><arg name="last">Pendergrast<space/></arg><arg name="first">Mark<space/></arg><arg name="authorlink"><space/>Mark Pendergrast</arg><arg name="title">Uncommon Grounds: The History of Coffee and How It Transformed Our World<space/></arg><arg name="publisher">Texere<space/></arg><arg name="location">London<space/></arg><arg name="year">2001<space/></arg><arg name="origyear">1999<space/></arg><arg name="isbn">1-58799-088-1<space/></arg><arg name="ref">CITEREFPendergrast2001</arg></template></listitem></list><heading level='2'>External links</heading><paragraph><template><target>Commons</target></template><template><target>Wikinews</target><arg>Alzheimer's disease reversed in mice using caffeine</arg></template></paragraph><list type='bullet'><listitem><link type='external' href='http://gmd.mpimp-golm.mpg.de/Spectrums/43595824-4FD6-4B29-AFC2-2771E487F6F3.aspx'>GMD MS Spectrum</link></listitem><listitem><link type='external' href='http://www.druglibrary.org/schaffer/Library/studies/cu/CU21.html'>The Consumers Union Report on Licit and Illicit Drugs, Caffeine-Part 1</link><space/><link type='external' href='http://www.druglibrary.org/schaffer/Library/studies/cu/CU22.html'>Part 2</link></listitem><listitem><link type='external' href='http://chemsub.online.fr/name/Caffeine.html'>Caffeine: ChemSub Online</link></listitem><listitem><link type='external' href='http://www.periodicvideos.com/videos/mv_caffeine.htm'>Caffeine</link><space/>at<space/><italics><link><target>The Periodic Table of Videos</target></link></italics><space/>(University of Nottingham)</listitem><listitem><link type='external' href='http://www.cdc.gov/niosh/ipcsneng/neng0405.html'>Caffeine International Chemical Safety Cards</link></listitem><listitem><template><target>cite web</target><arg name="url">http://www.mayoclinic.com/health/caffeine/AN01211<space/></arg><arg name="title">Caffeine content for coffee, tea, soda and more</arg><arg name="author">Mayo Clinic staff</arg><arg name="date">3 October 2009</arg><arg name="publisher">[[Mayo Clinic]]<space/></arg><arg name="accessdate">8 November 2010</arg></template></listitem></list><paragraph><template><target>Coffee</target><arg name="nocat">1</arg></template><template><target>Stimulants</target></template><template><target>Nootropics</target></template><template><target>Adenosinergics</target></template><template><target>Cholinergics</target></template><template><target>Glycinergics</target></template><template><target>Portal bar</target><arg>Pharmacy and Pharmacology</arg><arg>Chemistry</arg><arg>Coffee</arg></template></paragraph><paragraph><template><target>Authority control</target></template></paragraph><paragraph><link><target>Category:Caffeine</target><part></part></link><link><target>Category:Adenosine receptor antagonists</target></link><link><target>Category:Anxiogenics</target></link><link><target>Category:Bitter compounds</target></link><link><target>Category:Glycine receptor antagonists</target></link><link><target>Category:IARC Group 3 carcinogens</target></link><link><target>Category:Mutagens</target></link><link><target>Category:Phosphodiesterase inhibitors</target></link><link><target>Category:Plant toxin insecticides</target></link><link><target>Category:Substance intoxication</target></link><link><target>Category:Vasoconstrictors</target></link><link><target>Category:Xanthines</target></link><link><target>Category:Alkaloids found in plants</target></link></paragraph></article>